b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2811892/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811892/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Critical Care" /><meta name="citation_title" content="Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza" /><meta name="citation_authors" content="Jesus F Bermejo-Martin, Raul Ortiz de Lejarazu, Tomas Pumarola, Jordi Rello, Raquel Almansa, Paula Ram\xc3\xadrez, Ignacio Martin-Loeches, David Varillas, Maria C Gallegos, Carlos Ser\xc3\xb3n, Dariela Micheloud, JoseManuel Gomez, Alberto Tenorio-Abreu, Mar\xc3\xada J Ramos, MLourdes Molina, Samantha Huidobro, Elia Sanchez, M\xc3\xb3nica Gord\xc3\xb3n, Victoria Fern\xc3\xa1ndez, Alberto del Castillo, Ma\xc3\x81ngeles Marcos, Beatriz Villanueva, CarlosJavier L\xc3\xb3pez, Mario Rodr\xc3\xadguez-Dom\xc3\xadnguez, Juan-Carlos Galan, Rafael Cant\xc3\xb3n, Aurora Lietor, Silvia Rojo, Jose M Eiros, Carmen Hinojosa, Isabel Gonzalez, Nuria Torner, David Banner, Alberto Leon, Pablo Cuesta, Thomas Rowe, David J Kelvin" /><meta name="citation_date" content="2009" /><meta name="citation_volume" content="13" /><meta name="citation_doi" content="10.1186/cc8208" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2811892/?report=abstract" /><meta name="citation_pmid" content="20003352" /><meta name="DC.Title" content="Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Jesus F Bermejo-Martin" /><meta name="DC.Contributor" content="Raul Ortiz de Lejarazu" /><meta name="DC.Contributor" content="Tomas Pumarola" /><meta name="DC.Contributor" content="Jordi Rello" /><meta name="DC.Contributor" content="Raquel Almansa" /><meta name="DC.Contributor" content="Paula Ram\xc3\xadrez" /><meta name="DC.Contributor" content="Ignacio Martin-Loeches" /><meta name="DC.Contributor" content="David Varillas" /><meta name="DC.Contributor" content="Maria C Gallegos" /><meta name="DC.Contributor" content="Carlos Ser\xc3\xb3n" /><meta name="DC.Contributor" content="Dariela Micheloud" /><meta name="DC.Contributor" content="JoseManuel Gomez" /><meta name="DC.Contributor" content="Alberto Tenorio-Abreu" /><meta name="DC.Contributor" content="Mar\xc3\xada J Ramos" /><meta name="DC.Contributor" content="MLourdes Molina" /><meta name="DC.Contributor" content="Samantha Huidobro" /><meta name="DC.Contributor" content="Elia Sanchez" /><meta name="DC.Contributor" content="M\xc3\xb3nica Gord\xc3\xb3n" /><meta name="DC.Contributor" content="Victoria Fern\xc3\xa1ndez" /><meta name="DC.Contributor" content="Alberto del Castillo" /><meta name="DC.Contributor" content="Ma\xc3\x81ngeles Marcos" /><meta name="DC.Contributor" content="Beatriz Villanueva" /><meta name="DC.Contributor" content="CarlosJavier L\xc3\xb3pez" /><meta name="DC.Contributor" content="Mario Rodr\xc3\xadguez-Dom\xc3\xadnguez" /><meta name="DC.Contributor" content="Juan-Carlos Galan" /><meta name="DC.Contributor" content="Rafael Cant\xc3\xb3n" /><meta name="DC.Contributor" content="Aurora Lietor" /><meta name="DC.Contributor" content="Silvia Rojo" /><meta name="DC.Contributor" content="Jose M Eiros" /><meta name="DC.Contributor" content="Carmen Hinojosa" /><meta name="DC.Contributor" content="Isabel Gonzalez" /><meta name="DC.Contributor" content="Nuria Torner" /><meta name="DC.Contributor" content="David Banner" /><meta name="DC.Contributor" content="Alberto Leon" /><meta name="DC.Contributor" content="Pablo Cuesta" /><meta name="DC.Contributor" content="Thomas Rowe" /><meta name="DC.Contributor" content="David J Kelvin" /><meta name="DC.Date" content="2009" /><meta name="DC.Identifier" content="10.1186/cc8208" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza" /><meta property="og:type" content="article" /><meta property="og:description" content="Human host immune response following infection with the new variant of A/H1N1 pandemic influenza virus (nvH1N1) is poorly understood. We utilize here systemic cytokine and antibody levels in evaluating differences in early immune response in both mild ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811892/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2811892/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2811892/pdf/13054_2009_Article_7626.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A05D1E9A3F72100000000046D046A.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC2811892</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">Critical Care</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Crit Care</span>. 2009; 13: R201. </span></div><div><span class="fm-vol-iss-date">Published online 2009 Dec 11. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2Fcc8208" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/cc8208</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2811892</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/20003352">20003352</a></div></div></div></div><h1 class="content-title">Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Bermejo-Martin%20JF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667146278000" co-class="co-affbox">Jesus F Bermejo-Martin</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Ortiz%20de%20Lejarazu%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667113137648" co-class="co-affbox">Raul Ortiz de Lejarazu</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Pumarola%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667146272992" co-class="co-affbox">Tomas Pumarola</a>,<sup>3</sup> <a href="/pubmed/?term=Rello%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667194080272" co-class="co-affbox">Jordi Rello</a>,<sup>4</sup> <a href="/pubmed/?term=Almansa%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667194077904" co-class="co-affbox">Raquel Almansa</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Ram%26%23x000ed%3Brez%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667194074800" co-class="co-affbox">Paula Ram&#x000ed;rez</a>,<sup>5</sup> <a href="/pubmed/?term=Martin-Loeches%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667154328816" co-class="co-affbox">Ignacio Martin-Loeches</a>,<sup>4</sup> <a href="/pubmed/?term=Varillas%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667154326448" co-class="co-affbox">David Varillas</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Gallegos%20MC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667149940480" co-class="co-affbox">Maria C Gallegos</a>,<sup>6</sup> <a href="/pubmed/?term=Ser%26%23x000f3%3Bn%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667149938112" co-class="co-affbox">Carlos Ser&#x000f3;n</a>,<sup>7</sup> <a href="/pubmed/?term=Micheloud%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667149935744" co-class="co-affbox">Dariela Micheloud</a>,<sup>8</sup> <a href="/pubmed/?term=Gomez%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667111353808" co-class="co-affbox">JoseManuel Gomez</a>,<sup>8</sup> <a href="/pubmed/?term=Tenorio-Abreu%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667111351440" co-class="co-affbox">Alberto Tenorio-Abreu</a>,<sup>9</sup> <a href="/pubmed/?term=Ramos%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667111349072" co-class="co-affbox">Mar&#x000ed;a J Ramos</a>,<sup>9</sup> <a href="/pubmed/?term=Molina%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667148472800" co-class="co-affbox">MLourdes Molina</a>,<sup>10</sup> <a href="/pubmed/?term=Huidobro%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667148470432" co-class="co-affbox">Samantha Huidobro</a>,<sup>11</sup> <a href="/pubmed/?term=Sanchez%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667148468064" co-class="co-affbox">Elia Sanchez</a>,<sup>12</sup> <a href="/pubmed/?term=Gord%26%23x000f3%3Bn%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667153720256" co-class="co-affbox">M&#x000f3;nica Gord&#x000f3;n</a>,<sup>5</sup> <a href="/pubmed/?term=Fern%26%23x000e1%3Bndez%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667153717888" co-class="co-affbox">Victoria Fern&#x000e1;ndez</a>,<sup>6</sup> <a href="/pubmed/?term=del%20Castillo%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667153715520" co-class="co-affbox">Alberto del Castillo</a>,<sup>13</sup> <a href="/pubmed/?term=Marcos%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667158621296" co-class="co-affbox">Ma&#x000c1;ngeles Marcos</a>,<sup>3</sup> <a href="/pubmed/?term=Villanueva%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667158618928" co-class="co-affbox">Beatriz Villanueva</a>,<sup>14</sup> <a href="/pubmed/?term=L%26%23x000f3%3Bpez%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667158616560" co-class="co-affbox">CarlosJavier L&#x000f3;pez</a>,<sup>14</sup> <a href="/pubmed/?term=Rodr%26%23x000ed%3Bguez-Dom%26%23x000ed%3Bnguez%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667152611056" co-class="co-affbox">Mario Rodr&#x000ed;guez-Dom&#x000ed;nguez</a>,<sup>15</sup> <a href="/pubmed/?term=Galan%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667152608688" co-class="co-affbox">Juan-Carlos Galan</a>,<sup>15</sup> <a href="/pubmed/?term=Cant%26%23x000f3%3Bn%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667152606320" co-class="co-affbox">Rafael Cant&#x000f3;n</a>,<sup>15</sup> <a href="/pubmed/?term=Lietor%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667152287312" co-class="co-affbox">Aurora Lietor</a>,<sup>16</sup> <a href="/pubmed/?term=Rojo%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667152284944" co-class="co-affbox">Silvia Rojo</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Eiros%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667152281840" co-class="co-affbox">Jose M Eiros</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Hinojosa%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667154685664" co-class="co-affbox">Carmen Hinojosa</a>,<sup>17</sup> <a href="/pubmed/?term=Gonzalez%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667154683296" co-class="co-affbox">Isabel Gonzalez</a>,<sup>17</sup> <a href="/pubmed/?term=Torner%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667152999488" co-class="co-affbox">Nuria Torner</a>,<sup>18</sup> <a href="/pubmed/?term=Banner%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667152997120" co-class="co-affbox">David Banner</a>,<sup>19</sup> <a href="/pubmed/?term=Leon%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667152994752" co-class="co-affbox">Alberto Leon</a>,<sup>20</sup> <a href="/pubmed/?term=Cuesta%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667146309360" co-class="co-affbox">Pablo Cuesta</a>,<sup>21</sup> <a href="/pubmed/?term=Rowe%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667146306992" co-class="co-affbox">Thomas Rowe</a>,<sup>19,</sup><sup>22</sup> and  <a href="/pubmed/?term=Kelvin%20DJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352" class="affpopup" co-rid="_co_idm140667146303888" co-class="co-affbox">David J Kelvin</a><sup>19,</sup><sup>20,</sup><sup>22</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140667146278000"><h3 class="no_margin">Jesus F Bermejo-Martin</h3><p><sup>1</sup>National Centre of Influenza, Hospital Cl&#x000ed;nico Universitario de Valladolid, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><p><sup>2</sup>Unidad de Investigaci&#x000f3;n en Infecci&#x000f3;n e Inmunidad- Microbiology Service, Hospital Cl&#x000ed;nico Universitario de Valladolid- IECSCYL, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><div>Find articles by <a href="/pubmed/?term=Bermejo-Martin%20JF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Jesus F Bermejo-Martin</a></div></div><div id="_co_idm140667113137648"><h3 class="no_margin">Raul Ortiz de Lejarazu</h3><p><sup>1</sup>National Centre of Influenza, Hospital Cl&#x000ed;nico Universitario de Valladolid, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><p><sup>2</sup>Unidad de Investigaci&#x000f3;n en Infecci&#x000f3;n e Inmunidad- Microbiology Service, Hospital Cl&#x000ed;nico Universitario de Valladolid- IECSCYL, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><div>Find articles by <a href="/pubmed/?term=Ortiz%20de%20Lejarazu%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Raul Ortiz de Lejarazu</a></div></div><div id="_co_idm140667146272992"><h3 class="no_margin">Tomas Pumarola</h3><p><sup>3</sup>Virology Laboratory, Hospital Clinic de Barcelona, Barcelona, Carrer de Casanova 143, 08036 Spain </p><div>Find articles by <a href="/pubmed/?term=Pumarola%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Tomas Pumarola</a></div></div><div id="_co_idm140667194080272"><h3 class="no_margin">Jordi Rello</h3><p><sup>4</sup>Critical Care Department, Joan XXIII University Hospital-CIBERes Enfermedades Respiratorias-IISPV, Tarragona, Mallafre Guasch 4, 43007 Spain </p><div>Find articles by <a href="/pubmed/?term=Rello%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Jordi Rello</a></div></div><div id="_co_idm140667194077904"><h3 class="no_margin">Raquel Almansa</h3><p><sup>1</sup>National Centre of Influenza, Hospital Cl&#x000ed;nico Universitario de Valladolid, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><p><sup>2</sup>Unidad de Investigaci&#x000f3;n en Infecci&#x000f3;n e Inmunidad- Microbiology Service, Hospital Cl&#x000ed;nico Universitario de Valladolid- IECSCYL, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><div>Find articles by <a href="/pubmed/?term=Almansa%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Raquel Almansa</a></div></div><div id="_co_idm140667194074800"><h3 class="no_margin">Paula Ram&#x000ed;rez</h3><p><sup>5</sup>Critical Care Department, Hospital Universitario La Fe, Valencia, Avda Campanar 21, 46009 Spain </p><div>Find articles by <a href="/pubmed/?term=Ram%26%23x000ed%3Brez%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Paula Ram&#x000ed;rez</a></div></div><div id="_co_idm140667154328816"><h3 class="no_margin">Ignacio Martin-Loeches</h3><p><sup>4</sup>Critical Care Department, Joan XXIII University Hospital-CIBERes Enfermedades Respiratorias-IISPV, Tarragona, Mallafre Guasch 4, 43007 Spain </p><div>Find articles by <a href="/pubmed/?term=Martin-Loeches%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Ignacio Martin-Loeches</a></div></div><div id="_co_idm140667154326448"><h3 class="no_margin">David Varillas</h3><p><sup>1</sup>National Centre of Influenza, Hospital Cl&#x000ed;nico Universitario de Valladolid, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><p><sup>2</sup>Unidad de Investigaci&#x000f3;n en Infecci&#x000f3;n e Inmunidad- Microbiology Service, Hospital Cl&#x000ed;nico Universitario de Valladolid- IECSCYL, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><div>Find articles by <a href="/pubmed/?term=Varillas%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">David Varillas</a></div></div><div id="_co_idm140667149940480"><h3 class="no_margin">Maria C Gallegos</h3><p><sup>6</sup>Microbiology Service, Hospital Son Llatzer, Palma de Mallorca, Ctra. Manacor, km 4, 07198 Spain </p><div>Find articles by <a href="/pubmed/?term=Gallegos%20MC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Maria C Gallegos</a></div></div><div id="_co_idm140667149938112"><h3 class="no_margin">Carlos Ser&#x000f3;n</h3><p><sup>7</sup>Intensive Care Unit, Hospital General San Jorge, Huesca, Avenida Mart&#x000ed;nez De Velasco 36, 22004&#x000fd; Spain </p><div>Find articles by <a href="/pubmed/?term=Ser%26%23x000f3%3Bn%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Carlos Ser&#x000f3;n</a></div></div><div id="_co_idm140667149935744"><h3 class="no_margin">Dariela Micheloud</h3><p><sup>8</sup>Intensive Care Unit &#x00026; Internal Medicine Service, Hospital Gregorio Mara&#x000f1;&#x000f3;n, Madrid, C/Doctor Esquerdo 46, 28007 Spain </p><div>Find articles by <a href="/pubmed/?term=Micheloud%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Dariela Micheloud</a></div></div><div id="_co_idm140667111353808"><h3 class="no_margin">JoseManuel Gomez</h3><p><sup>8</sup>Intensive Care Unit &#x00026; Internal Medicine Service, Hospital Gregorio Mara&#x000f1;&#x000f3;n, Madrid, C/Doctor Esquerdo 46, 28007 Spain </p><div>Find articles by <a href="/pubmed/?term=Gomez%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">JoseManuel Gomez</a></div></div><div id="_co_idm140667111351440"><h3 class="no_margin">Alberto Tenorio-Abreu</h3><p><sup>9</sup>Microbiology Service, Hospital Universitario de Canarias, Carretera Del Rosario 145, Santa Cruz De Tenerife&#x000fd;, 38009 Spain </p><div>Find articles by <a href="/pubmed/?term=Tenorio-Abreu%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Alberto Tenorio-Abreu</a></div></div><div id="_co_idm140667111349072"><h3 class="no_margin">Mar&#x000ed;a J Ramos</h3><p><sup>9</sup>Microbiology Service, Hospital Universitario de Canarias, Carretera Del Rosario 145, Santa Cruz De Tenerife&#x000fd;, 38009 Spain </p><div>Find articles by <a href="/pubmed/?term=Ramos%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Mar&#x000ed;a J Ramos</a></div></div><div id="_co_idm140667148472800"><h3 class="no_margin">MLourdes Molina</h3><p><sup>10</sup>Microbiology Service, Hospital General de La Palma, Bre&#x000f1;a Alta,, Buenavista de Arriba, s/n, 38713 Spain </p><div>Find articles by <a href="/pubmed/?term=Molina%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">MLourdes Molina</a></div></div><div id="_co_idm140667148470432"><h3 class="no_margin">Samantha Huidobro</h3><p><sup>11</sup>Intensive Care Unit, Hospital Universitario de Canarias, Bre&#x000f1;a Alt, Carretera Del Rosario 145, Santa Cruz De Tenerife&#x000fd;, 38009 Spain </p><div>Find articles by <a href="/pubmed/?term=Huidobro%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Samantha Huidobro</a></div></div><div id="_co_idm140667148468064"><h3 class="no_margin">Elia Sanchez</h3><p><sup>12</sup>Intensive Care Unit, Hospital Virgen del Roc&#x000ed;o, Sevilla, Avenida Manuel Siurot s/n, 41013 Spain </p><div>Find articles by <a href="/pubmed/?term=Sanchez%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Elia Sanchez</a></div></div><div id="_co_idm140667153720256"><h3 class="no_margin">M&#x000f3;nica Gord&#x000f3;n</h3><p><sup>5</sup>Critical Care Department, Hospital Universitario La Fe, Valencia, Avda Campanar 21, 46009 Spain </p><div>Find articles by <a href="/pubmed/?term=Gord%26%23x000f3%3Bn%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">M&#x000f3;nica Gord&#x000f3;n</a></div></div><div id="_co_idm140667153717888"><h3 class="no_margin">Victoria Fern&#x000e1;ndez</h3><p><sup>6</sup>Microbiology Service, Hospital Son Llatzer, Palma de Mallorca, Ctra. Manacor, km 4, 07198 Spain </p><div>Find articles by <a href="/pubmed/?term=Fern%26%23x000e1%3Bndez%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Victoria Fern&#x000e1;ndez</a></div></div><div id="_co_idm140667153715520"><h3 class="no_margin">Alberto del Castillo</h3><p><sup>13</sup>Intensive Care Unit Service, Hospital Son Llatzer, Palma de Mallorca, Ctra. Manacor, km 4, 07198 Spain </p><div>Find articles by <a href="/pubmed/?term=del%20Castillo%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Alberto del Castillo</a></div></div><div id="_co_idm140667158621296"><h3 class="no_margin">Ma&#x000c1;ngeles Marcos</h3><p><sup>3</sup>Virology Laboratory, Hospital Clinic de Barcelona, Barcelona, Carrer de Casanova 143, 08036 Spain </p><div>Find articles by <a href="/pubmed/?term=Marcos%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Ma&#x000c1;ngeles Marcos</a></div></div><div id="_co_idm140667158618928"><h3 class="no_margin">Beatriz Villanueva</h3><p><sup>14</sup>Intensive Care Unit Service, Hospital Lozano Blesa, Zaragoza&#x000fd;, Avenida San Juan Bosco 15, 50009 Spain </p><div>Find articles by <a href="/pubmed/?term=Villanueva%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Beatriz Villanueva</a></div></div><div id="_co_idm140667158616560"><h3 class="no_margin">CarlosJavier L&#x000f3;pez</h3><p><sup>14</sup>Intensive Care Unit Service, Hospital Lozano Blesa, Zaragoza&#x000fd;, Avenida San Juan Bosco 15, 50009 Spain </p><div>Find articles by <a href="/pubmed/?term=L%26%23x000f3%3Bpez%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">CarlosJavier L&#x000f3;pez</a></div></div><div id="_co_idm140667152611056"><h3 class="no_margin">Mario Rodr&#x000ed;guez-Dom&#x000ed;nguez</h3><p><sup>15</sup>Microbiology Service,CIBERESP, Hospital Universitario Ram&#x000f3;n y Cajal, Madrid, Carretera Colmenar Viejo KM 9,100, 28049 Spain </p><div>Find articles by <a href="/pubmed/?term=Rodr%26%23x000ed%3Bguez-Dom%26%23x000ed%3Bnguez%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Mario Rodr&#x000ed;guez-Dom&#x000ed;nguez</a></div></div><div id="_co_idm140667152608688"><h3 class="no_margin">Juan-Carlos Galan</h3><p><sup>15</sup>Microbiology Service,CIBERESP, Hospital Universitario Ram&#x000f3;n y Cajal, Madrid, Carretera Colmenar Viejo KM 9,100, 28049 Spain </p><div>Find articles by <a href="/pubmed/?term=Galan%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Juan-Carlos Galan</a></div></div><div id="_co_idm140667152606320"><h3 class="no_margin">Rafael Cant&#x000f3;n</h3><p><sup>15</sup>Microbiology Service,CIBERESP, Hospital Universitario Ram&#x000f3;n y Cajal, Madrid, Carretera Colmenar Viejo KM 9,100, 28049 Spain </p><div>Find articles by <a href="/pubmed/?term=Cant%26%23x000f3%3Bn%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Rafael Cant&#x000f3;n</a></div></div><div id="_co_idm140667152287312"><h3 class="no_margin">Aurora Lietor</h3><p><sup>16</sup>Intensive Care Unit, Hospital Universitario Ram&#x000f3;n y Cajal, Madrid, Carretera Colmenar Viejo KM 9,100, 28049 Spain </p><div>Find articles by <a href="/pubmed/?term=Lietor%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Aurora Lietor</a></div></div><div id="_co_idm140667152284944"><h3 class="no_margin">Silvia Rojo</h3><p><sup>1</sup>National Centre of Influenza, Hospital Cl&#x000ed;nico Universitario de Valladolid, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><p><sup>2</sup>Unidad de Investigaci&#x000f3;n en Infecci&#x000f3;n e Inmunidad- Microbiology Service, Hospital Cl&#x000ed;nico Universitario de Valladolid- IECSCYL, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><div>Find articles by <a href="/pubmed/?term=Rojo%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Silvia Rojo</a></div></div><div id="_co_idm140667152281840"><h3 class="no_margin">Jose M Eiros</h3><p><sup>1</sup>National Centre of Influenza, Hospital Cl&#x000ed;nico Universitario de Valladolid, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><p><sup>2</sup>Unidad de Investigaci&#x000f3;n en Infecci&#x000f3;n e Inmunidad- Microbiology Service, Hospital Cl&#x000ed;nico Universitario de Valladolid- IECSCYL, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><div>Find articles by <a href="/pubmed/?term=Eiros%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Jose M Eiros</a></div></div><div id="_co_idm140667154685664"><h3 class="no_margin">Carmen Hinojosa</h3><p><sup>17</sup>Infectious Diseases Service, Hospital Cl&#x000ed;nico Universitario, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><div>Find articles by <a href="/pubmed/?term=Hinojosa%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Carmen Hinojosa</a></div></div><div id="_co_idm140667154683296"><h3 class="no_margin">Isabel Gonzalez</h3><p><sup>17</sup>Infectious Diseases Service, Hospital Cl&#x000ed;nico Universitario, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </p><div>Find articles by <a href="/pubmed/?term=Gonzalez%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Isabel Gonzalez</a></div></div><div id="_co_idm140667152999488"><h3 class="no_margin">Nuria Torner</h3><p><sup>18</sup>Preventive Medicine Service,CIBERESP, Hospital Universitario Valle Hebron, Barcelona, Paseo Vall d\'Hebron, 119-129, 08035 Spain </p><div>Find articles by <a href="/pubmed/?term=Torner%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Nuria Torner</a></div></div><div id="_co_idm140667152997120"><h3 class="no_margin">David Banner</h3><p><sup>19</sup>Experimental Theraputics Division, University Health Network, Toronto, Medical Discovery Tower, 3rd floor Room 913-916,101 Collegue Street, M5G 1L7 Canada </p><div>Find articles by <a href="/pubmed/?term=Banner%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">David Banner</a></div></div><div id="_co_idm140667152994752"><h3 class="no_margin">Alberto Leon</h3><p><sup>20</sup>International Institute of Infection and Immunity, Shantou University, Shantou, 22 Xinling Road, Guangdong Province 515031 PR China </p><div>Find articles by <a href="/pubmed/?term=Leon%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Alberto Leon</a></div></div><div id="_co_idm140667146309360"><h3 class="no_margin">Pablo Cuesta</h3><p><sup>21</sup>Intensive Care Unit, Hospital de Villarobredo, Villarrobledo, Avenida Miguel de Cervantes s/n, 02600 Spain </p><div>Find articles by <a href="/pubmed/?term=Cuesta%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Pablo Cuesta</a></div></div><div id="_co_idm140667146306992"><h3 class="no_margin">Thomas Rowe</h3><p><sup>19</sup>Experimental Theraputics Division, University Health Network, Toronto, Medical Discovery Tower, 3rd floor Room 913-916,101 Collegue Street, M5G 1L7 Canada </p><p><sup>22</sup>Department of Immunology, University of Toronto, Toronto, Medical Discovery Tower, 3rd floor Room 913-916,101 Collegue Street, M5G 1L7 Canada </p><div>Find articles by <a href="/pubmed/?term=Rowe%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">Thomas Rowe</a></div></div><div id="_co_idm140667146303888"><h3 class="no_margin">David J Kelvin</h3><p><sup>19</sup>Experimental Theraputics Division, University Health Network, Toronto, Medical Discovery Tower, 3rd floor Room 913-916,101 Collegue Street, M5G 1L7 Canada </p><p><sup>20</sup>International Institute of Infection and Immunity, Shantou University, Shantou, 22 Xinling Road, Guangdong Province 515031 PR China </p><p><sup>22</sup>Department of Immunology, University of Toronto, Toronto, Medical Discovery Tower, 3rd floor Room 913-916,101 Collegue Street, M5G 1L7 Canada </p><div>Find articles by <a href="/pubmed/?term=Kelvin%20DJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20003352">David J Kelvin</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140667151857920_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140667151857920_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140667151857920_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140667151857920_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>National Centre of Influenza, Hospital Cl&#x000ed;nico Universitario de Valladolid, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>Unidad de Investigaci&#x000f3;n en Infecci&#x000f3;n e Inmunidad- Microbiology Service, Hospital Cl&#x000ed;nico Universitario de Valladolid- IECSCYL, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </div><div class="fm-affl" lang="en" id="Aff3"><sup>3</sup>Virology Laboratory, Hospital Clinic de Barcelona, Barcelona, Carrer de Casanova 143, 08036 Spain </div><div class="fm-affl" lang="en" id="Aff4"><sup>4</sup>Critical Care Department, Joan XXIII University Hospital-CIBERes Enfermedades Respiratorias-IISPV, Tarragona, Mallafre Guasch 4, 43007 Spain </div><div class="fm-affl" lang="en" id="Aff5"><sup>5</sup>Critical Care Department, Hospital Universitario La Fe, Valencia, Avda Campanar 21, 46009 Spain </div><div class="fm-affl" lang="en" id="Aff6"><sup>6</sup>Microbiology Service, Hospital Son Llatzer, Palma de Mallorca, Ctra. Manacor, km 4, 07198 Spain </div><div class="fm-affl" lang="en" id="Aff7"><sup>7</sup>Intensive Care Unit, Hospital General San Jorge, Huesca, Avenida Mart&#x000ed;nez De Velasco 36, 22004&#x000fd; Spain </div><div class="fm-affl" lang="en" id="Aff8"><sup>8</sup>Intensive Care Unit &#x00026; Internal Medicine Service, Hospital Gregorio Mara&#x000f1;&#x000f3;n, Madrid, C/Doctor Esquerdo 46, 28007 Spain </div><div class="fm-affl" lang="en" id="Aff9"><sup>9</sup>Microbiology Service, Hospital Universitario de Canarias, Carretera Del Rosario 145, Santa Cruz De Tenerife&#x000fd;, 38009 Spain </div><div class="fm-affl" lang="en" id="Aff10"><sup>10</sup>Microbiology Service, Hospital General de La Palma, Bre&#x000f1;a Alta,, Buenavista de Arriba, s/n, 38713 Spain </div><div class="fm-affl" lang="en" id="Aff11"><sup>11</sup>Intensive Care Unit, Hospital Universitario de Canarias, Bre&#x000f1;a Alt, Carretera Del Rosario 145, Santa Cruz De Tenerife&#x000fd;, 38009 Spain </div><div class="fm-affl" lang="en" id="Aff12"><sup>12</sup>Intensive Care Unit, Hospital Virgen del Roc&#x000ed;o, Sevilla, Avenida Manuel Siurot s/n, 41013 Spain </div><div class="fm-affl" lang="en" id="Aff13"><sup>13</sup>Intensive Care Unit Service, Hospital Son Llatzer, Palma de Mallorca, Ctra. Manacor, km 4, 07198 Spain </div><div class="fm-affl" lang="en" id="Aff14"><sup>14</sup>Intensive Care Unit Service, Hospital Lozano Blesa, Zaragoza&#x000fd;, Avenida San Juan Bosco 15, 50009 Spain </div><div class="fm-affl" lang="en" id="Aff15"><sup>15</sup>Microbiology Service,CIBERESP, Hospital Universitario Ram&#x000f3;n y Cajal, Madrid, Carretera Colmenar Viejo KM 9,100, 28049 Spain </div><div class="fm-affl" lang="en" id="Aff16"><sup>16</sup>Intensive Care Unit, Hospital Universitario Ram&#x000f3;n y Cajal, Madrid, Carretera Colmenar Viejo KM 9,100, 28049 Spain </div><div class="fm-affl" lang="en" id="Aff17"><sup>17</sup>Infectious Diseases Service, Hospital Cl&#x000ed;nico Universitario, Valladolid, Avda Ram&#x000f3;n y Cajal 3, 47005 Spain </div><div class="fm-affl" lang="en" id="Aff18"><sup>18</sup>Preventive Medicine Service,CIBERESP, Hospital Universitario Valle Hebron, Barcelona, Paseo Vall d\'Hebron, 119-129, 08035 Spain </div><div class="fm-affl" lang="en" id="Aff19"><sup>19</sup>Experimental Theraputics Division, University Health Network, Toronto, Medical Discovery Tower, 3rd floor Room 913-916,101 Collegue Street, M5G 1L7 Canada </div><div class="fm-affl" lang="en" id="Aff20"><sup>20</sup>International Institute of Infection and Immunity, Shantou University, Shantou, 22 Xinling Road, Guangdong Province 515031 PR China </div><div class="fm-affl" lang="en" id="Aff21"><sup>21</sup>Intensive Care Unit, Hospital de Villarobredo, Villarrobledo, Avenida Miguel de Cervantes s/n, 02600 Spain </div><div class="fm-affl" lang="en" id="Aff22"><sup>22</sup>Department of Immunology, University of Toronto, Toronto, Medical Discovery Tower, 3rd floor Room 913-916,101 Collegue Street, M5G 1L7 Canada </div><div><span class="fm-affl">Jesus F Bermejo-Martin, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.noelyallitsacdulas@ojemrebfj" class="oemail">se.noelyallitsacdulas@ojemrebfj</a></span>.</div><div><a href="#idm140667151857920aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140667151857920_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2009 Nov 4; Revised 2009 Dec 3; Accepted 2009 Dec 11.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140667151857920_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Bermejo-Martin et al.; licensee BioMed Central Ltd. 2009</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2811892/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2>Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Additional file 1: Table listing the immune mediators\' profiles in serum during the early response against the nvH1N1 virus. (DOC 88 KB)</div><div><a href="/pmc/articles/PMC2811892/bin/13054_2009_7626_MOESM1_ESM.doc" data-ga-action="click_feat_suppl">13054_2009_7626_MOESM1_ESM.doc</a><span style="color:gray"> (89K)</span></div><div class="small guid">GUID:\xc2\xa020F600D2-2A3A-476E-A143-20E727862A85</div></div></dd></dl></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Introduction</h3><p id="__p1" class="p p-first-last">Human host immune response following infection with the new variant of A/H1N1 pandemic influenza virus (nvH1N1) is poorly understood. We utilize here systemic cytokine and antibody levels in evaluating differences in early immune response in both mild and severe patients infected with nvH1N1.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p2" class="p p-first-last">We profiled 29 cytokines and chemokines and evaluated the haemagglutination inhibition activity as quantitative and qualitative measurements of host immune responses in serum obtained during the first five days after symptoms onset, in two cohorts of nvH1N1 infected patients. Severe patients required hospitalization (n = 20), due to respiratory insufficiency (10 of them were admitted to the intensive care unit), while mild patients had exclusively flu-like symptoms (n = 15). A group of healthy donors was included as control (n = 15). Differences in levels of mediators between groups were assessed by using the non parametric U-Mann Whitney test. Association between variables was determined by calculating the Spearman correlation coefficient. Viral load was performed in serum by using real-time PCR targeting the neuraminidase gene.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p3" class="p p-first-last">Increased levels of innate-immunity mediators (IP-10, MCP-1, MIP-1&#x003b2;), and the absence of anti-nvH1N1 antibodies, characterized the early response to nvH1N1 infection in both hospitalized and mild patients. High systemic levels of type-II interferon (IFN-&#x003b3;) and also of a group of mediators involved in the development of T-helper 17 (IL-8, IL-9, IL-17, IL-6) and T-helper 1 (TNF-&#x003b1;, IL-15, IL-12p70) responses were exclusively found in hospitalized patients. IL-15, IL-12p70, IL-6 constituted a hallmark of critical illness in our study. A significant inverse association was found between IL-6, IL-8 and PaO2 in critical patients.</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Conclusions</h3><p id="__p4" class="p p-first-last">While infection with the nvH1N1 induces a typical innate response in both mild and severe patients, severe disease with respiratory involvement is characterized by early secretion of Th17 and Th1 cytokines usually associated with cell mediated immunity but also commonly linked to the pathogenesis of autoimmune/inflammatory diseases. The exact role of Th1 and Th17 mediators in the evolution of nvH1N1 mild and severe disease merits further investigation as to the detrimental or beneficial role these cytokines play in severe illness.</p></div><div id="__sec5" class="sec sec-last"><h3 id="__sec5title">Electronic supplementary material</h3><p id="__p5" class="p p-first-last">The online version of this article (doi:10.1186/cc8208) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Influenza, Host Immune Response, Oseltamivir, Haemagglutination Inhibition, Immune Mediator</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Introduction</h2><p id="__p6" class="p p-first-last">The emergence of the new pandemic variant of influenza virus (nvH1N1) has brought renewed attention to the strategies for prevention, treatment and minimization of the social and human costs of the influenza disease [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922758">1</a>&#x02013;<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922764">5</a>]. The great majority of nvH1N1 infections are mild and self-limiting in nature [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922760">6</a>&#x02013;<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922743">8</a>]. Nevertheless, a small percentage of the patients require hospitalization and specialized attention in Intensive Care Units (ICUs) [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922733">9</a>&#x02013;<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922753">12</a>]. Many severe cases occur in healthy young adults, an age group rarely seriously affected by seasonal influenza [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922736">9</a>&#x02013;<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922737">14</a>]. While pregnancy and metabolic conditions (including obesity and diabetes) have been identified as risk factors for severe nvH1N1 disease, 40 to 50% of fatal cases have no documented underlying medical condition [<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922754">11</a>, <a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922739">12</a>, <a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922735">14</a>]. The new virus causes more severe pathological lesions in the lungs of infected mice, ferrets and non-human primates than seasonal human H1N1 virus [<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922756">15</a>]. The role of host immune responses in clearance of nvH1N1 or the role, if any, of host immune responses in contributing to severe respiratory pathogenesis of nvH1N1 infections is not known at this time. We have previously identified specific host immune response chemokine and cytokine signatures in severe and mild SARS CoV, H5N1 and Respiratory Syncytial Virus infections. In these studies, early host immune responses are characterized by the expression of systemic levels of chemokines, such as CXCL10, indicative of innate anti viral responses [<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922734">16</a>&#x02013;<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922750">19</a>]. Severe and mild SARS and RSV illness could further be defined by chemokine and cytokine signatures involved in the development of adaptive immunity. Interestingly, de Jong <em>et al</em>. have demonstrated that <em>hypercytokinemia</em> of specific chemokines and cytokines is associated with severe and often fatal cases of human H5N1 infections [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922745">20</a>]. To determine if host immune responses play a potential role in the evolution of mild or severe nvH1N1 illness we performed an analysis of systemic chemokine and cytokine levels in serum from severe and mild nvH1N1 patients shortly following the onset of symptoms. Interestingly, we identified cytokine signatures unique to mild and severe patients.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Materials and methods</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Patients and controls</h3><p id="__p7" class="p p-first">Both hospitalized and outpatients were recruited during the first pandemic wave in the months of July and August 2009 in 10 different hospitals within the National Public Health System of Spain.</p><p id="__p8">Inclusion criteria: Critical patients with respiratory insufficiency, hospitalized non critical patients with respiratory insufficiency, and mild outpatients with no respiratory insufficiency attending to the participant centers with confirmed nvH1N1 infection by molecular diagnostic methods (see below) were asked to donate a serum sample for the study in the first contact with the participant physicians. Initially we enrolled 35 hospitalized patients and 31 outpatients. To determine systemic levels of chemokines and cytokines in sera from nvH1N1 infected individuals, we analyzed sera from 20 hospitalized, 15 outpatients, and 15 control subjects for levels of 29 different mediators. The final number of patients used for analysis was based on exclusion and matching criteria listed in Figure <a href="/pmc/articles/PMC2811892/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1</span></span><span>1</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC2811892/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140667150911712" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13054_2009_Article_7626_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 13054_2009_Article_7626_Fig1_HTML.jpg" src="/pmc/articles/PMC2811892/bin/13054_2009_Article_7626_Fig1_HTML.jpg" /></div><div id="largeobj_idm140667150911712" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2811892/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC2811892/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p9">Flow chart detailing patients\' recruitment and sample collection.</p></div></div></div><p id="__p10" class="p p-last">Exclusion criteria: Patients with signs of bacterial infection defined by the presence of purulent respiratory secretions, and/or positive results in respiratory cultures, blood cultures, and/or positive urinary antigen test to <em>Legionella pneumophila</em> or <em>Streptococcus pneumoniae</em> were excluded from the analysis (Figure <a href="/pmc/articles/PMC2811892/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure1).</span></span><span>1</span></a>). Children under 16 years old and one patient older than 80 years old were also excluded in order to make groups comparable by age. Pregnant women were also excluded to avoid confusion factors during the analysis of the immune response to the virus, since pregnancy induces physiological changes in the immune system (Figure <a href="/pmc/articles/PMC2811892/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure1).</span></span><span>1</span></a>). Informed consent was obtained directly from each patient or their legal representative and also from the healthy controls before enrollment. Approval of the study protocol in both the scientific and the ethical aspects was obtained from the Scientific Committee for Clinical Research of the coordinating center (Hospital Clinico Universitario de Valladolid, Spain).</p></div><div id="Sec4" class="sec"><h3 id="Sec4title">Samples and laboratory studies</h3><div id="Sec5" class="sec sec-first"><p></p><h4 id="Sec5title" class="inline">Sample collection and transport </h4><p id="__p11" class="p p-first-last">Blood samples were collected by experienced nurses. A single serum sample was obtained from each patient or control. Serum samples were obtained after proper centrifugation and were sent refrigerated to the National Influenza Center of Valladolid (Spain), where they were stored at -70&#x000b0;C until immune mediator profiling, haemagglutination inhibition activity (HI) and viral load evaluation. Nasopharyngeal swabs preserved in virus transportation medium were sent to the World Health Organization (WHO) associated National Influenza Centers of Valladolid, Majadahonda and Barcelona, Spain for viral diagnosis purposes.</p></div><div id="Sec6" class="sec"><p></p><h4 id="Sec6title" class="inline">Viral diagnosis </h4><p id="__p12" class="p p-first-last">Viral RNA from nasopharyngeal swabs was obtained by using automatic extractors (Biomerieux<sup>&#x000ae;</sup> (Marcy l\'Etoile, France), Roche<sup>&#x000ae;</sup> (Basel, Switzerland) and viral presence was assessed by real time PCR based methods using reagents provided free of charge by the Centers for Disease Control (CDC, Atlanta, USA) or purchased from Roche<sup>&#x000ae;</sup> (Basel, Switzerland) (H1N1 detection set) on 96-well plate termocyclers (Roche<sup>&#x000ae;</sup> LC480 (Basel, Switzerland) and Applied Biosystems<sup>&#x000ae;</sup> 7500 (Foster City, CA, USA)</p></div><div id="Sec7" class="sec"><p></p><h4 id="Sec7title" class="inline">Viral load measurement </h4><p id="__p13" class="p p-first-last">Viral load was measured and compared between groups by real time reverse transcription PCR on RNA extracted from serum. Briefly, an external curve was obtained by using a serial dilution of human RNA extracted from cultured monocytic leukemia (THP-1) cells, and human gene GAPDH was employed as reporter gene. nvH1N1 neuraminidase gene was amplified by QRT-PCR in each serum sample, and crossing points were extrapolated to the external curve. Analysis of samples and standard curve was conducted by using the 7500 fast v2.0.3 software (Applied Biosystem&#x02122;). Results were given as relative comparisons in (pg RNA/&#x003bc;l). 5\'-3\' sequences of primer pairs: GAPDH 5\'-ACCCAGAAGACTGTGGATGG-3\' (forward); 5\'-TTCTAGACGGCAGGTCAGGT-3\' (reverse); nvH1N1 neuraminidase: 5\'-TCAGTCGAAATGAATGCCCTAA-3\' (forward) and N1R 5\'-CACGGTCGATTCGAGCCATG-3\'(reverse).</p></div><div id="Sec8" class="sec"><p></p><h4 id="Sec8title" class="inline">Cytokines and chemokines quantification </h4><p id="__p14" class="p p-first-last">Serum chemokine and cytokine levels were evaluated using the multiplex Biorad<sup>&#x000a9;</sup> 27 plex assay (Hercules, CA, USA). This system allows for quantitative measurement of 27 different chemokines, cytokines, growth-factors and immune mediators while consuming a small amount of biological material. Furthermore, this system has good representation of analytes for inflammatory cytokines, anti-inflammatory cytokines, Th1 cytokines, Th2 cytokines, Th17 cytokines and chemokines, allowing for the testing of differential levels of regulatory cytokines in the serum of severe and mild patients. Additionally, interferon &#x003b1;, adiponectin and leptin were measured by using an enzyme-linked inmuno adsorbant assay (ELISA) from R&#x00026;D<sup>&#x000a9;</sup> Systems (Minneapolis, MN, USA).</p></div><div id="Sec9" class="sec sec-last"><p></p><h4 id="Sec9title" class="inline">Haemagglutination inhibition assay (HI) </h4><p id="__p15" class="p p-first-last">HI assays were performed on a 100 &#x003bc;l aliquot of the samples at University Health Network (UHN), Toronto, Ontario, Canada. The sera was treated with Receptor-Destroying Enzyme (RDE) of <em>V. cholerae</em> by diluting one part serum with three parts enzyme and were incubated overnight in a 37&#x000b0;C water bath. The enzyme was inactivated by a 30-minute incubation at 56&#x000b0;C followed by the addition of six parts 0.85% physiological saline for a final dilution of 1/10. HI assays were performed in V-bottom 96-well microtiter plates (Corning Costar Co., Cambridge, MA, USA) with 0.5% turkey erythrocytes, as previously described [<a href="#CR21" rid="CR21" class=" bibr popnode">21</a>], using inactivated pandemic influenza A/California/07/2009 (nvH1N1) antigens.</p></div></div><div id="Sec10" class="sec sec-last"><h3 id="Sec10title">Statistical analysis</h3><p id="__p16" class="p p-first-last">Data analysis was performed using SPSS 15.0. Comparisons between groups were performed using the non parametric U-Mann Whitney test. Data are displayed as (mean, standard deviation) for clinical and laboratory parameters and as (median, interquartile rank) for data on sample collection timing and the immune mediators levels. Association between variables was determined by calculating the Spearman correlation coefficient (r) and data shown as (r, <em>P</em> value). Significance was fixed at <em>P</em> value &#x0003c; 0.05</p></div></div><div id="Sec11" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec11title">Results</h2><div id="Sec12" class="sec sec-first"><h3 id="Sec12title">Patient\'s characteristics</h3><p id="__p17" class="p p-first-last">All the patients showed symptoms of acute respiratory viral infection at disease onset. The most frequent initial symptoms were (% of patients in each group: critical, hospitalized non critical, outpatients): fever (100, 100, 80), cough (100, 90, 80), headache (90, 80, 40), tiredness (100, 80, 66) and myalgia (50, 80, 46). Hospitalized patients showed dyspnoea as the initial symptom in 90% of the cases and 100% developed respiratory insufficiency at the time of hospital admission (dyspnoea and/or hypoxemia defined as O2 saturation &#x0003c; 95% breathing at least two liters of oxygen). Ten patients required admission to an intensive care unit (ICU) due to their respiratory situation. The remaining 10 were admitted to other different specialized hospital services. Outpatients had no difficulties with respiratory function, showing respiratory rates under 25&#x000d7;\'. Sex composition was the same for both critical and non critical hospitalized patients: 60% of the patients were male (n = 12) and 40% female (n = 8). Fifty-three percent of the outpatients were male and 47% female (n = 8 and 7 respectively) (Table <a href="/pmc/articles/PMC2811892/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). Average age was as follows: hospitalized patients (36.6; 11.5), outpatients (29.7; 8.0) and healthy controls, (29.5; 13.2). Critical patients were slightly older than the other hospitalized patients (Table <a href="/pmc/articles/PMC2811892/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). Seven patients with critical illness and four severe patients with non critical illness showed previous pathologies (Table <a href="/pmc/articles/PMC2811892/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). Ten out of 10 of the critical patients, and 6/10 of the severe non critical patients showed a pathological chest x-ray within 24 hours of onset of the symptoms (Table <a href="/pmc/articles/PMC2811892/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). Outpatients had received just antipyretics (paracetamol) before sample collection (none of them had received oseltamivir). One hundred percent of the hospitalized patients (critical and non critical), had received oseltamivir at the time of sample collection (Table <a href="/pmc/articles/PMC2811892/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). Lymphopenia was a common finding in the critical patients (mean; SD) (358.5; 267.1). LDH levels were increased over normal levels in hospitalized patients, mostly in those critically ill (Table <a href="/pmc/articles/PMC2811892/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). Furthermore, critical patients also showed high levels of CPK, GOT, GPT and glucose in venous blood (Table <a href="/pmc/articles/PMC2811892/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). Critical patients stayed longer at the hospital than the other hospitalized patients (Table <a href="/pmc/articles/PMC2811892/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). Three critical patients ultimately died (five days after onset due to hypoxemia and septic shock; 69 days after onset by refractory hypoxemia complicated by systemic candidiasis; and the third after 75 days of supportive therapy by multiorganic failure).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p18">Clinical and laboratory characteristics of the patients</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140667159085680" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">Hospitalized, critical illness(n = 10)</th><th align="center" rowspan="1" colspan="1">Hospitalized, non critical illness (n = 10)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">\n<strong>Pathological antecedents</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">Esquizophrenia</td><td align="center" rowspan="1" colspan="1">1/10</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">COPD</td><td align="center" rowspan="1" colspan="1">1/10</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1">2/10</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">Asthma</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">2/10</td></tr><tr><td align="center" rowspan="1" colspan="1">COPD+HIV</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1/10</td></tr><tr><td align="center" rowspan="1" colspan="1">Chronic disease conective tissue</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1/10</td></tr><tr><td align="center" rowspan="1" colspan="1">Dyslipemia</td><td align="center" rowspan="1" colspan="1">1/10</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">Cardiopathy</td><td align="center" rowspan="1" colspan="1">1/10</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">1/10</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">Obesity (BMI&#x0003e;30)</td><td align="center" rowspan="1" colspan="1">5/10</td><td align="center" rowspan="1" colspan="1">3/10</td></tr><tr><td align="center" rowspan="1" colspan="1">\n<strong>Descriptives</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">Age (yrs)</td><td align="center" rowspan="1" colspan="1">41.8 (9.9)</td><td align="center" rowspan="1" colspan="1">31.3 (10.9)</td></tr><tr><td align="center" rowspan="1" colspan="1">Sex (M/F)</td><td align="center" rowspan="1" colspan="1">6/4</td><td align="center" rowspan="1" colspan="1">6/4</td></tr><tr><td align="center" rowspan="1" colspan="1">Days at hospital</td><td align="center" rowspan="1" colspan="1">29.5 (29.2)</td><td align="center" rowspan="1" colspan="1">6.5 (2.8)</td></tr><tr><td align="center" rowspan="1" colspan="1">Days at ICU</td><td align="center" rowspan="1" colspan="1">26.6 (30.8)</td><td align="center" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="center" rowspan="1" colspan="1">\n<strong>Severity scores</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">SOFA score</td><td align="center" rowspan="1" colspan="1">5.6 (2.9)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">APACHEII score</td><td align="center" rowspan="1" colspan="1">12.8 (4.2)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">\n<strong>Respiratory condition</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">Mechanical Ventilation</td><td align="center" rowspan="1" colspan="1">9/10</td><td align="center" rowspan="1" colspan="1">0/10</td></tr><tr><td align="center" rowspan="1" colspan="1">O2 saturation (%)</td><td align="center" rowspan="1" colspan="1">83.3 (7.3)</td><td align="center" rowspan="1" colspan="1">93.0 (5.1)</td></tr><tr><td align="center" rowspan="1" colspan="1">PaO2 (mmHg)</td><td align="center" rowspan="1" colspan="1">54.1 (11.6)</td><td align="center" rowspan="1" colspan="1">76.5 (24.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">PaO2:FiO2</td><td align="center" rowspan="1" colspan="1">94.0 (89.9)</td><td align="center" rowspan="1" colspan="1">252.5 (20.6)</td></tr><tr><td align="center" rowspan="1" colspan="1">\n<strong>Opacity in initial chest X-Ray</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">0/4 quadrants</td><td align="center" rowspan="1" colspan="1">0/10</td><td align="center" rowspan="1" colspan="1">4/10</td></tr><tr><td align="center" rowspan="1" colspan="1">1/4 quadrants</td><td align="center" rowspan="1" colspan="1">2/10</td><td align="center" rowspan="1" colspan="1">3/10</td></tr><tr><td align="center" rowspan="1" colspan="1">2/4 quadrants</td><td align="center" rowspan="1" colspan="1">3/10</td><td align="center" rowspan="1" colspan="1">3/10</td></tr><tr><td align="center" rowspan="1" colspan="1">3/4 quadrants</td><td align="center" rowspan="1" colspan="1">0/10</td><td align="center" rowspan="1" colspan="1">0/10</td></tr><tr><td align="center" rowspan="1" colspan="1">4/4 quadrants</td><td align="center" rowspan="1" colspan="1">5/10</td><td align="center" rowspan="1" colspan="1">0/10</td></tr><tr><td align="center" rowspan="1" colspan="1">\n<strong>Biochemistry</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">LDH (IU/liter)</td><td align="center" rowspan="1" colspan="1">1634 (1226.0)</td><td align="center" rowspan="1" colspan="1">475.1 (356.7)</td></tr><tr><td align="center" rowspan="1" colspan="1">CPK (IU/liter)</td><td align="center" rowspan="1" colspan="1">588.5 (606.1)</td><td align="center" rowspan="1" colspan="1">108.5 (132.1)</td></tr><tr><td align="center" rowspan="1" colspan="1">GOT (U/liter)</td><td align="center" rowspan="1" colspan="1">126.9 (73.5)</td><td align="center" rowspan="1" colspan="1">35.6 (14.5)</td></tr><tr><td align="center" rowspan="1" colspan="1">GPT (U/liter)</td><td align="center" rowspan="1" colspan="1">130.7 (97.6)</td><td align="center" rowspan="1" colspan="1">35.7 (18.9)</td></tr><tr><td align="center" rowspan="1" colspan="1">Glucose (mg/dl)</td><td align="center" rowspan="1" colspan="1">202.7 (97.1)</td><td align="center" rowspan="1" colspan="1">113.1 (29.1)</td></tr><tr><td align="center" rowspan="1" colspan="1">CRP (mg/l)</td><td align="center" rowspan="1" colspan="1">85.4 (76.3)</td><td align="center" rowspan="1" colspan="1">61.1 (105.1)</td></tr><tr><td align="center" rowspan="1" colspan="1">\n<strong>Treatment received at the time of sample collection</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">Oseltamivir</td><td align="center" rowspan="1" colspan="1">10/10 (75-150 mg/12 hs)</td><td align="center" rowspan="1" colspan="1">10/10 (75 mg/12 hs)</td></tr><tr><td align="center" rowspan="1" colspan="1">Cephalosporines</td><td align="center" rowspan="1" colspan="1">6/10</td><td align="center" rowspan="1" colspan="1">2/10</td></tr><tr><td align="center" rowspan="1" colspan="1">Macrolides</td><td align="center" rowspan="1" colspan="1">3/10</td><td align="center" rowspan="1" colspan="1">1/10</td></tr><tr><td align="center" rowspan="1" colspan="1">Quinolones</td><td align="center" rowspan="1" colspan="1">5/10</td><td align="center" rowspan="1" colspan="1">7/10</td></tr><tr><td align="center" rowspan="1" colspan="1">Steroids</td><td align="center" rowspan="1" colspan="1">4/10 (parenteral)</td><td align="center" rowspan="1" colspan="1">2/10 (inhaled)</td></tr><tr><td align="center" rowspan="1" colspan="1">Noradrenaline</td><td align="center" rowspan="1" colspan="1">5/10</td><td align="center" rowspan="1" colspan="1">0/10</td></tr><tr><td align="center" rowspan="1" colspan="1">Renal replacement therapy</td><td align="center" rowspan="1" colspan="1">2/10</td><td align="center" rowspan="1" colspan="1">0/10</td></tr></tbody></table></div><div id="largeobj_idm140667159085680" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2811892/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p19">COPD = Chronic Obstructive Pulmonary Disease; HIV = Human Immunodeficiency Virus; BMI = Body Mass Index; ICU = Intensive Care Unit; SOFA = Sepsis-related Organ Failure Assessment score; APACHE II = Acute Physiology and Chronic Health Evaluation II; PaO2 = pressure of oxygen in arterial blood; FiO2 = fraction of inspired oxygen; LDH = Lactate dehydrogenase; CPK = creatine phosphokinase; GOT = Glutamyl oxaloacetic transaminase; GPT = Glutamyl pyruvic transaminase; CRP = C Reactive Protein; IU = International Units; U = Units.</p></div></div></div><div id="Sec13" class="sec"><h3 id="Sec13title">HI activity</h3><p id="__p20" class="p p-first-last">HI activity (A/California/07/2009) was present in serum from only two critically ill patients of 50 and 51 years old (titres 1/1280 and 1/160 respectively) and in one 25-year-old outpatient (titre 1/160). Serum from those three patients showing HI showed also the ability to block viral replication, as assessed by microneutralization assay against A/California/07/2009 (data not shown). This data supports the notion that at the time of sampling the vast majority of the patients had yet to produce antibodies against nvH1N1 and was in the early stages of disease.</p></div><div id="Sec14" class="sec sec-last"><h3 id="Sec14title">Immune mediators profiling</h3><p id="__p21" class="p p-first">The virus induced in both mild and severe patients a systemic elevation of three chemokines that have been shown to be expressed early during viral infections, CXCL-10 (IP-10), CCL-2 (MCP-1) and CCL-4 (MIP-1&#x003b2;), with no differences in the levels of these mediators between them (data on immune mediators profiling are shown in Figure <a href="/pmc/articles/PMC2811892/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure2</span></span><span>2</span></a> and Additional file <a href="#MOESM1" rid="MOESM1" class=" media">1</a>). IL-8, IFN-&#x003b3;, IL-13, IL-10 levels were higher in the hospitalized patients than in outpatients and controls (<em>P</em> &#x0003c; 0.05). IL-9 behaved in a similar way. While both critical and non-critical hospitalized patients showed higher levels of IL-17 and TNF-&#x003b1; than controls, only severe non critical patients showed significant higher levels of IL-17 and TNF-&#x003b1; than mild. On the other hand, IL-15 and IL-12p70 increased exclusively in critical patients, who in addition showed the highest levels of IL-6 of the compared groups.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC2811892/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140667159018592" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13054_2009_Article_7626_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 13054_2009_Article_7626_Fig2_HTML.jpg" src="/pmc/articles/PMC2811892/bin/13054_2009_Article_7626_Fig2_HTML.jpg" /></div><div id="largeobj_idm140667159018592" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2811892/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC2811892/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p22">Levels of immune mediators in the four groups. *Significant differences with control at the level <em>P</em> &#x0003c; 0.05.</p></div></div></div><p id="__p23" class="p p-last">To determine if systemic viral load plays a role in chemokine or cytokine expression levels we evaluated serum for nvH1N1 levels. Fifty-seven percent of critical patients, 50% of hospitalized non critical patients, and 93% of mild patients showed positive virus in serum. For those with positive virus in serum, we found no differences in viral load between critical patients, hospitalized non critically ill, and mild outpatients (Figure <a href="/pmc/articles/PMC2811892/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3).</span></span><span>3</span></a>). We found significantly higher levels of IL-13 and IL-17 in those hospitalized patients with negative virus in serum compared to those with virus in serum (data not shown). Similarly, inverse correlations were found between viral load and IL-13, IL-17 in patients requiring hospital admission (Figure <a href="/pmc/articles/PMC2811892/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure4).</span></span><span>4</span></a>). When mediator levels were correlated with the clinical parameters, a significant inverse association was found between IL-6 and PaO2 in hospitalized patients (Figure <a href="/pmc/articles/PMC2811892/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure4).</span></span><span>4</span></a>). Exclusively in the critical patients group, IL-8 inversely correlated with PaO2 [-0.7; 0.028]. In the non critically ill hospitalized patients group, a negative association was observed between IL-15 and PaO2 [-0.7; 0.039].</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC2811892/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140667155163520" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13054_2009_Article_7626_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 13054_2009_Article_7626_Fig3_HTML.jpg" src="/pmc/articles/PMC2811892/bin/13054_2009_Article_7626_Fig3_HTML.jpg" /></div><div id="largeobj_idm140667155163520" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2811892/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC2811892/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p24">Viral load in serum. (From left to right: 0: critical patients; 1: hospitalized (non critical) patients; 2: mild outpatients). Results are expressed as (pg RNA/&#x003bc;l).</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC2811892/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140667155160128" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13054_2009_Article_7626_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 13054_2009_Article_7626_Fig4_HTML.jpg" src="/pmc/articles/PMC2811892/bin/13054_2009_Article_7626_Fig4_HTML.jpg" /></div><div id="largeobj_idm140667155160128" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2811892/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC2811892/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p25">Correlation studies. From left to right: correlation between IL-13 level and viral load in serum; correlation between IL-17 level and viral load in serum; correlation between IL-6 serum levels and PaO2.</p></div></div></div></div></div><div id="Sec15" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec15title">Discussion</h2><p id="__p26" class="p p-first">In a first attempt to understand the role host immune responses play in the evolution of severe and mild nvH1N1 disease, we assessed systemic levels of chemokines and cytokines in the sera from hospitalized and outpatients. Consistent with our previous studies on early elevated expression of CXCL10, CCL2 and CCL4 in SARS CoV and RSV infected patients [<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922755">16</a>&#x02013;<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922741">19</a>], we found in the present study elevated expression of these chemokines in severe patients (critical and non critical) and mild patients. The early expression of these chemokines in all patients likely is indicative of innate antiviral host responses.</p><p id="__p27">One of the most intriguing observations in our present study is the dramatic increase of mediators which stimulate Th-1 responses (IFN-&#x003b3;, TNF-&#x003b1;, IL-15, IL-12p70) and Th-17 ones (IL-8, IL-9, IL-17, IL-6) in the severe patients (Figure <a href="/pmc/articles/PMC2811892/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure5).</span></span><span>5</span></a>). Th-1 adaptive immunity is an important response against intracellular microbes such as viruses [<a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922748">22</a>]. Th-17 immunity participates in clearing pathogens during host defense reactions but is involved also in tissue inflammation in several autoimmune diseases, allergic diseases, and asthma [<a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922744">23</a>&#x02013;<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922746">27</a>].</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC2811892/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140667152684720" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13054_2009_Article_7626_Fig5_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 13054_2009_Article_7626_Fig5_HTML.jpg" src="/pmc/articles/PMC2811892/bin/13054_2009_Article_7626_Fig5_HTML.jpg" /></div><div id="largeobj_idm140667152684720" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2811892/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC2811892/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Figure 5</a></div><!--caption a7--><div class="caption"><p id="__p28">Predominant cytokine profiles paralleling early nvH1N1 disease by clinical severity.</p></div></div></div><p id="__p29">Increase in IFN-&#x003b3; IL-8, IL-9, IL-13 and IL-10 in both critical and non critical hospitalized patients compared to mild ones indicates that they constitute hallmarks of severe disease. IFN-&#x003b3; and IL-8 promote antiviral immunity but also respiratory tract inflammation by recruiting neutrophils and mononuclear cells to the site of the infection [<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922762">28</a>&#x02013;<a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922742">30</a>]. IL-9 is a Th2 cytokine that induces differentiation of Th-17 cells [<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922757">26</a>]. IL-10 and IL-13 show immunomodulatory properties. IL-13 attenuates Th-17 cytokine production [<a href="#CR31" rid="CR31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922759">31</a>]. IL-10 is known to be an anti-inflammatory cytokine. In a murine model, McKinstry <em>et al</em>.revealed that IL-10 inhibits development of Th-17 responses during influenza infection, correlating with compromised protection [<a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922749">32</a>]. Increase of IL-17 and TNF-&#x003b1; in hospitalized patients over control indicated that they also parallel severe disease, but the significantly higher levels of IL-17 and TNF-&#x003b1; in severe non critical patients compared to mild (difference not found for critical ones), could reflect a beneficial role of these cytokines in this particular subset of patients. The patient who died five days after disease onset showed high viral load and undetectable IL-17 levels in serum. This could reflect a protective role of IL-17 in severe patients. IL-15, IL-12p70, IL-6 constituted a hallmark of critical illness in our study. These three cytokines also mediate both antiviral and pro-inflammatory responses. IL-6 is a potent regulator switching immune responses from the induction of Foxp3+ regulatory T cells to pathogenic Th17 cells <em>in vivo</em> [<a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922740">33</a>]. IL-15 promotes CD8 T cells homeostatic proliferation [<a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922747">34</a>] in response to infection. IL-12 plays a key role in the switch from innate to adaptive immunity [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848473550">17</a>].</p><p id="__p30" class="p p-last">High levels of Th-1 and Th-17 related mediators could support the hypothesis of a Th-1+Th-17 inflammatory response in the origin of the severe respiratory disease caused by nvH1N1 infection. Alternatively, an increase in Th-1 and Th-17 cytokines may reflect a vigorous antiviral host response necessary for clearance of virus during severe lower respiratory infections. While the ability of influenza A virus to induce the production of chemotactic (RANTES, MIP-1&#x003b1;, MCP-1, MCP-3, and IP-10) and pro-inflammatory (IL-1&#x003b2;, IL-6, IL-18, and TNF-&#x003b1;) Th1 related mediators is well know from previous reports on seasonal influenza [<a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922751">29</a>, <a href="#CR35" rid="CR35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922738">35</a>], this is the first report evidencing Th17 response as a signature of severe influenza disease in humans [<a href="#CR36" rid="CR36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922732">36</a>, <a href="#CR37" rid="CR37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844922761">37</a>]. Since there are immunomodulatory drugs which have shown to down-modulate the activity of both Th1 and Th17 [<a href="#CR38" rid="CR38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848473549">38</a>], the results obtained here supports the development of further studies on animal models aimed to clarify the role of these mediators in the pathogenesis of the acute respiratory disease showed by severe nvH1N1 infected patients.</p></div><div id="Sec16" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec16title">Conclusions</h2><p id="__p31" class="p p-first-last">Analysis of the immune mediators involved in host responses to the virus in mild and severe cases revealed Th1 and Th17 cytokine responses as early distinctive hallmarks of severe respiratory compromise following infection with nvH1N1. The exact role of Th1 and Th17 mediators in the evolution of nvH1N1 mild and severe disease merits further investigation as to the detrimental or beneficial role these cytokines play in severe illness. The influence of Th17-dominant conditions (autoimmune diseases) or Th1 deficient ones (HIV infection) on disease outcome should also be explored. Furthermore, the impact of other regulatory cytokines elevated in severe disease (IL-10, IL-13) on the evolution of host immune responses to nvH1N1 infections may represent alternative therapeutics for controlling severe illness.</p></div><div id="Sec17" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec17title">Key messages</h2><p id="__p32" class="p p-first-last">\n</p><ul class="unordered" style="list-style-type:disc"><!--\nlist-behavior=unordered\nprefix-word=\nmark-type=disc\nmax-label-size=0\n--><li><p id="__p33">The great majority of infections caused by the new influenza pandemic virus are mild and self-limiting in nature. Nevertheless, a small percentage of the patients develop severe respiratory disease. Analysis of the immune mediators involved in host responses to the virus along with the evaluation of the humoral responses in mild and severe cases may help understand the pathogenic events leading to poor outcomes.</p></li><li><p id="__p34">Early response to the virus in both hospitalized and outpatients was characterized by expression of chemokines (CXCL10, CCL2 and CCL4), also observed in the response to SARS CoV, H5N1 and RSV, which previous literature describes to correspond to innate antiviral responses.</p></li><li><p id="__p35">Patients who develop respiratory compromise in the first days following infection with nvH1N typically showed Th1 and Th17 hyper-cytokinemia, compared to mild patients and healthy controls. These cytokine profiles have been previously reported to participate in both antiviral and pro-inflammatory responses.</p></li><li><p id="__p36">Increased systemic levels of IL-15, IL-12p70, IL-6 constituted a hallmark of critical illness. These mediators are known to promote the development of adaptive responses and also pro-inflammatory ones in other viral infections.</p></li><li><p id="__p37">Our findings constitute a major avenue to guide the design of further works studying the beneficial or detrimental role of Th1 and Th17 responses in this disease.</p></li></ul><p>\n</p></div><div id="__sec6" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="__sec6title">Electronic supplementary material</h2><!--/article/body/sec/--><div id="Sec18" class="sec sec-first-last"><p id="__p38" class="p p-first-last">\n</p><div class="sec suppmat" id="MOESM1"><div class="sup-box half_rhythm" id="idm140667153622288"><a href="/pmc/articles/PMC2811892/bin/13054_2009_7626_MOESM1_ESM.doc" data-ga-action="click_feat_suppl">Additional file 1: Table listing the immune mediators\' profiles in serum during the early response against the nvH1N1 virus. (DOC 88 KB)</a><sup>(89K, doc)</sup></div></div><p>\n</p></div></div><div id="idm140667148109936" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140667148109936title">Acknowledgements</h2><div class="sec"><p id="__p66">This work has been made by an international team pertaining to the <em>Spanish-Canadian Consortium for the Study of Influenza Immuno-pathogenesis</em>. The authors would like to thank Lucia Rico and Ver&#x000f3;nica Iglesias for their assistance in the technical development of the multiplex cytokine assays, to Bego&#x000f1;a Nogueira for her technical support, and to Nikki Kelvin for language revision of this article. This work was possible thanks to the financial support obtained from the Ministry of Science of Spain and <em>Consejer&#x000ed;a de Sanidad Junta de Castilla y Le&#x000f3;n</em>, <em>Programa de investigaci&#x000f3;n comisionada en gripe</em>, GR09/0021, <em>Programa para favorecer la incorporaci&#x000f3;n de grupos de investigaci&#x000f3;n en las Instituciones del Sistema Nacional de Salud</em>, EMER07/050, and <em>Proyectos en Investigaci&#x000f3;n Sanitaria</em>, PI081236. CIHR, NIH and LKSF-Canada support DJK. This sponsorship made possible reagent acquisition and sample transportation between participant groups.</p></div></div><div id="idm140667149832400" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140667149832400title">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>FGF-b</td><td>Human Fibroblast Growth Factor-basic</td></tr><tr><td>G-CSF</td><td>granulocyte colony-stimulating factor</td></tr><tr><td>GM-CSF</td><td>granulocyte macrophage colony-stimulating factor</td></tr><tr><td>IFN-&#x003b1;</td><td>interferon alpha</td></tr><tr><td>IFN-&#x003b3;</td><td>interferon &#x003b3;</td></tr><tr><td>IL-1RA</td><td>Interleukin 1 receptor antagonist</td></tr><tr><td>IP-10</td><td>Interferon-inducible protein-10</td></tr><tr><td>MCP-1</td><td>monocyte chemoattractant protein-1</td></tr><tr><td>MIP-1&#x003b1;</td><td>macrophage inflammatory protein-1&#x003b1;</td></tr><tr><td>MIP-1&#x003b2;</td><td>macrophage inflammatory protein-1&#x003b2;</td></tr><tr><td>nvH1N1</td><td>nvH1N1</td></tr><tr><td>NVHIV</td><td>new variant of H1N1 influenza virus</td></tr><tr><td>PDGF-BB</td><td>platelet-derived growth factor</td></tr><tr><td>TNF-&#x003b1;</td><td>tumour necrosis factor &#x003b1;</td></tr><tr><td>VEGF</td><td>vascular endothelial growth factor.</td></tr></tbody></table></div></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec19" class="sec sec-first"><h3 id="Sec19title">Authors&#x02019; original submitted files for images</h3><p id="__p40" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC2811892/bin/13054_2009_7626_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(31K, pdf)</sup></span><span class="sup-box" id="MOESM3"><a href="/pmc/articles/PMC2811892/bin/13054_2009_7626_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(107K, pdf)</sup></span><span class="sup-box" id="MOESM4"><a href="/pmc/articles/PMC2811892/bin/13054_2009_7626_MOESM4_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 3</a><sup>(20K, pdf)</sup></span><span class="sup-box" id="MOESM5"><a href="/pmc/articles/PMC2811892/bin/13054_2009_7626_MOESM5_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 4</a><sup>(67K, pdf)</sup></span><span class="sup-box" id="MOESM6"><a href="/pmc/articles/PMC2811892/bin/13054_2009_7626_MOESM6_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 5</a><sup>(84K, pdf)</sup></span><span class="sup-box" id="MOESM7"><a href="/pmc/articles/PMC2811892/bin/13054_2009_7626_MOESM7_ESM.doc" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 6</a><sup>(50K, doc)</sup></span></p></div></div><div id="idm140667148113888" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140667148113888title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140667148113760"><p id="__p62" class="p p-first"><strong>Competing interests</strong></p><p id="__p63" class="p p-last">The authors declare that they have no competing interests.</p></p><p class="fn sec" id="idm140667148112352"><p id="__p64" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p65" class="p p-last">TP, JR and IML assisted in the design of the study, coordinated patient recruitment, analysed and interpreted the data, and assisted in writing the paper. PR, MCG, CS, DM, JMG, SH, ES, MG, AC, BV, CJL, JAD, CH, IG and PC supervised clinical aspects, participated in patient recruitment, assisted in the analysis, interpretation of data, and writing the report. AT, MJR, MLM, VF, MAM, MRD, JCG, RC, SR and JME performed viral diagnosis, assisted in the analysis, interpretation of data, and writing the report. RA performed cytokine profiling, and assisted in supervision of laboratory work and writing the report. NT collected clinical data, and assisted in writing the report. TR, DB performed the HAI assays and assisted in writing the report. DV and AL designed and performed the quantitative PCR method for viral load measurement. JFBM, DJK and ROL were the primary investigators, designed the study, coordinated patient recruitment, supervised laboratory works, and wrote the article.</p></p></div></div><div id="idm140667151857920aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140667151857920aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Jesus F Bermejo-Martin, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.noelyallitsacdulas@ojemrebfj" class="oemail">se.noelyallitsacdulas@ojemrebfj</a></span>.</p><p><span class="fm-affl">Raul Ortiz de Lejarazu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.lycas.vuch@zitror" class="oemail">se.lycas.vuch@zitror</a></span>.</p><p><span class="fm-affl">Tomas Pumarola, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.bu.cinilc@ALORAMUP" class="oemail">se.bu.cinilc@ALORAMUP</a></span>.</p><p><span class="fm-affl">Jordi Rello, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="tac.tacneg@sci.32jh.ollerj" class="oemail">tac.tacneg@sci.32jh.ollerj</a></span>.</p><p><span class="fm-affl">Raquel Almansa, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.lycscei@asnamlar" class="oemail">moc.lycscei@asnamlar</a></span>.</p><p><span class="fm-affl">Paula Ram&#x000ed;rez, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.avg@uap_zerimar" class="oemail">se.avg@uap_zerimar</a></span>.</p><p><span class="fm-affl">Ignacio Martin-Loeches, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@sehceolnitramrd" class="oemail">moc.liamg@sehceolnitramrd</a></span>.</p><p><span class="fm-affl">David Varillas, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@gled_sallrv_d" class="oemail">moc.liamtoh@gled_sallrv_d</a></span>.</p><p><span class="fm-affl">Maria C Gallegos, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.llsh@sogellagcm" class="oemail">se.llsh@sogellagcm</a></span>.</p><p><span class="fm-affl">Carlos Ser&#x000f3;n, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@ranoresc" class="oemail">moc.liamg@ranoresc</a></span>.</p><p><span class="fm-affl">Dariela Micheloud, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.oohay@yradduolehcim" class="oemail">se.oohay@yradduolehcim</a></span>.</p><p><span class="fm-affl">JoseManuel Gomez, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@aicragzemogames" class="oemail">moc.liamtoh@aicragzemogames</a></span>.</p><p><span class="fm-affl">Alberto Tenorio-Abreu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.lycas.vuch@oironeta" class="oemail">se.lycas.vuch@oironeta</a></span>.</p><p><span class="fm-affl">Mar&#x000ed;a J Ramos, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@laersomaresojm" class="oemail">moc.liamtoh@laersomaresojm</a></span>.</p><p><span class="fm-affl">MLourdes Molina, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.sairanacedonreibog@loblomm" class="oemail">gro.sairanacedonreibog@loblomm</a></span>.</p><p><span class="fm-affl">Samantha Huidobro, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@mas.luosmirglip" class="oemail">moc.liamg@mas.luosmirglip</a></span>.</p><p><span class="fm-affl">Elia Sanchez, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.arret@sonabarredlavse" class="oemail">se.arret@sonabarredlavse</a></span>.</p><p><span class="fm-affl">M&#x000f3;nica Gord&#x000f3;n, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.vmoc@sgacinom" class="oemail">se.vmoc@sgacinom</a></span>.</p><p><span class="fm-affl">Victoria Fern&#x000e1;ndez, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.llsh@acab-zednanrefv" class="oemail">se.llsh@acab-zednanrefv</a></span>.</p><p><span class="fm-affl">Alberto del Castillo, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.llsh@llitsaca" class="oemail">se.llsh@llitsaca</a></span>.</p><p><span class="fm-affl">Ma&#x000c1;ngeles Marcos, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.bu.cinilc@SOCRAMM" class="oemail">se.bu.cinilc@SOCRAMM</a></span>.</p><p><span class="fm-affl">Beatriz Villanueva, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@nodanavb" class="oemail">moc.liamg@nodanavb</a></span>.</p><p><span class="fm-affl">CarlosJavier L&#x000f3;pez, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@odisnus" class="oemail">moc.liamtoh@odisnus</a></span>.</p><p><span class="fm-affl">Mario Rodr&#x000ed;guez-Dom&#x000ed;nguez, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.dirdam.dulas@crh.zeugirdorjm" class="oemail">gro.dirdam.dulas@crh.zeugirdorjm</a></span>.</p><p><span class="fm-affl">Juan-Carlos Galan, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.dirdam.dulas@crh.mnalagj" class="oemail">gro.dirdam.dulas@crh.mnalagj</a></span>.</p><p><span class="fm-affl">Rafael Cant&#x000f3;n, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.dirdam.dulas@crh.notnacr" class="oemail">gro.dirdam.dulas@crh.notnacr</a></span>.</p><p><span class="fm-affl">Aurora Lietor, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.nsm@roteilarorua" class="oemail">moc.nsm@roteilarorua</a></span>.</p><p><span class="fm-affl">Silvia Rojo, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@oller_ojor_aivlis" class="oemail">moc.liamtoh@oller_ojor_aivlis</a></span>.</p><p><span class="fm-affl">Jose M Eiros, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.avu.dem@sorie" class="oemail">se.avu.dem@sorie</a></span>.</p><p><span class="fm-affl">Carmen Hinojosa, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.lycas.vuch@asojonihm" class="oemail">se.lycas.vuch@asojonihm</a></span>.</p><p><span class="fm-affl">Isabel Gonzalez, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.ono@64lebasi" class="oemail">moc.ono@64lebasi</a></span>.</p><p><span class="fm-affl">Nuria Torner, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="tac.tacneg@renrot.airun" class="oemail">tac.tacneg@renrot.airun</a></span>.</p><p><span class="fm-affl">David Banner, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.otnorotu.sernhu@rennabd" class="oemail">ac.otnorotu.sernhu@rennabd</a></span>.</p><p><span class="fm-affl">Alberto Leon, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.oohay@noeljotrebla" class="oemail">se.oohay@noeljotrebla</a></span>.</p><p><span class="fm-affl">Pablo Cuesta, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.oohay@atseucolbap" class="oemail">se.oohay@atseucolbap</a></span>.</p><p><span class="fm-affl">Thomas Rowe, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.oohay@1eworsamoht" class="oemail">moc.oohay@1eworsamoht</a></span>.</p><p><span class="fm-affl">David J Kelvin, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.hcraesernhu@nivlekd" class="oemail">ac.hcraesernhu@nivlekd</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>:2605\xe2\x80\x932615. doi: 10.1056/NEJMoa0903810.</span> [<a href="/pubmed/19423869" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa0903810" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Emergence+of+a+novel+swine-origin+influenza+A+(H1N1)+virus+in+humans&amp;author=FS+Dawood&amp;author=S+Jain&amp;author=L+Finelli&amp;author=MW+Shaw&amp;author=S+Lindstrom&amp;volume=360&amp;publication_year=2009&amp;pages=2605-2615&amp;pmid=19423869&amp;doi=10.1056/NEJMoa0903810&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Lurie N. H1N1 influenza, public health preparedness, and health care reform. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">361</span>:843\xe2\x80\x93845. doi: 10.1056/NEJMp0905330.</span> [<a href="/pubmed/19710481" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMp0905330" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=H1N1+influenza,+public+health+preparedness,+and+health+care+reform&amp;author=N+Lurie&amp;volume=361&amp;publication_year=2009&amp;pages=843-845&amp;pmid=19710481&amp;doi=10.1056/NEJMp0905330&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Cohen J, Enserink M. Swine flu. After delays, WHO agrees: the 2009 pandemic has begun. <span><span class="ref-journal">Science. </span>2009;<span class="ref-vol">324</span>:1496\xe2\x80\x931497. doi: 10.1126/science.324_1496.</span> [<a href="/pubmed/19541958" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.324_1496" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Swine+flu.+After+delays,+WHO+agrees:+the+2009+pandemic+has+begun&amp;author=J+Cohen&amp;author=M+Enserink&amp;volume=324&amp;publication_year=2009&amp;pages=1496-1497&amp;pmid=19541958&amp;doi=10.1126/science.324_1496&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Cohen J. Public health. A race against time to vaccinate against novel H1N1 virus. <span><span class="ref-journal">Science. </span>2009;<span class="ref-vol">325</span>:1328\xe2\x80\x931329. doi: 10.1126/science.325_1328.</span> [<a href="/pubmed/19745124" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.325_1328" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Public+health.+A+race+against+time+to+vaccinate+against+novel+H1N1+virus&amp;author=J+Cohen&amp;volume=325&amp;publication_year=2009&amp;pages=1328-1329&amp;pmid=19745124&amp;doi=10.1126/science.325_1328&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM., Jr The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus. <span><span class="ref-journal">Science. </span>2009;<span class="ref-vol">326</span>:729\xe2\x80\x9333. doi: 10.1126/science.1177373.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2880578/">PMC free article</a>]</span> [<a href="/pubmed/19745114" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.1177373" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+Transmissibility+and+Control+of+Pandemic+Influenza+A+(H1N1)+Virus&amp;author=Y+Yang&amp;author=JD+Sugimoto&amp;author=ME+Halloran&amp;author=NE+Basta&amp;author=DL+Chao&amp;volume=326&amp;publication_year=2009&amp;pages=729-33&amp;pmid=19745114&amp;doi=10.1126/science.1177373&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Nicoll A, Coulombier D. Europe\'s initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices. <span><span class="ref-journal">Euro Surveill. </span>2009;<span class="ref-vol">14</span>:19279.</span> [<a href="/pubmed/19643049" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Euro+Surveill&amp;title=Europe\'s+initial+experience+with+pandemic+(H1N1)+2009+-+mitigation+and+delaying+policies+and+practices&amp;author=A+Nicoll&amp;author=D+Coulombier&amp;volume=14&amp;publication_year=2009&amp;pages=19279&amp;pmid=19643049&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Health Protection Agency. Health Protection Scotland. National Public Health Service for Wales. HPA Northern Ireland Swine influenza investigation teams  Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April-June 2009. <span><span class="ref-journal">Euro Surveill. </span>2009;<span class="ref-vol">14</span>:19232.</span> [<a href="/pubmed/19497255" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Euro+Surveill&amp;title=Epidemiology+of+new+influenza+A+(H1N1)+virus+infection,+United+Kingdom,+April-June+2009&amp;volume=14&amp;publication_year=2009&amp;pages=19232&amp;pmid=19497255&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Gilsdorf A, Poggensee G. Influenza A(H1N1)v in Germany: the first 10,000 cases. <span><span class="ref-journal">Euro Surveill. </span>2009;<span class="ref-vol">14</span>:19318.</span> [<a href="/pubmed/19712649" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Euro+Surveill&amp;title=Influenza+A(H1N1)v+in+Germany:+the+first+10,000+cases&amp;author=A+Gilsdorf&amp;author=G+Poggensee&amp;volume=14&amp;publication_year=2009&amp;pages=19318&amp;pmid=19712649&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">ANZIC Influenza Investigators. Webb SA, Pettil&#x000e4; V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, Hart GK, Howe B, Iredell JR, McArthur C, Mitchell I, Morrison S, Nichol AD, Paterson DL, Peake S, Richards B, Stephens D, Turner A, Yung M. Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">361</span>:1925\xe2\x80\x931934. doi: 10.1056/NEJMoa0908481.</span> [<a href="/pubmed/19815860" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa0908481" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Critical+Care+Services+and+2009+H1N1+Influenza+in+Australia+and+New+Zealand&amp;author=SA+Webb&amp;author=V+Pettil&#x000e4;&amp;author=I+Seppelt&amp;author=R+Bellomo&amp;author=M+Bailey&amp;volume=361&amp;publication_year=2009&amp;pages=1925-1934&amp;pmid=19815860&amp;doi=10.1056/NEJMoa0908481&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L. Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">361</span>:1935\xe2\x80\x931944. doi: 10.1056/NEJMoa0906695.</span> [<a href="/pubmed/19815859" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa0906695" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Hospitalized+Patients+with+2009+H1N1+Influenza+in+the+United+States,+April-June+2009&amp;author=S+Jain&amp;author=L+Kamimoto&amp;author=AM+Bramley&amp;author=AM+Schmitz&amp;author=SR+Benoit&amp;volume=361&amp;publication_year=2009&amp;pages=1935-1944&amp;pmid=19815859&amp;doi=10.1056/NEJMoa0906695&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, et al.  Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada. <span><span class="ref-journal">JAMA. </span>2009;<span class="ref-vol">302</span>:1872\xe2\x80\x939. doi: 10.1001/jama.2009.1496.</span> [<a href="/pubmed/19822627" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1001%2Fjama.2009.1496" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Critically+Ill+Patients+With+2009+Influenza+A(H1N1)+Infection+in+Canada&amp;author=A+Kumar&amp;author=R+Zarychanski&amp;author=R+Pinto&amp;author=DJ+Cook&amp;author=J+Marshall&amp;volume=302&amp;publication_year=2009&amp;pages=1872-9&amp;pmid=19822627&amp;doi=10.1001/jama.2009.1496&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Rello J, Rodr&#x000ed;guez A, Iba&#x000f1;ez P, Socias L, Cebrian J, Marques A, Guerrero J, Ruiz-Santana S, Marquez E, Del Nogal-Saez F, Alvarez-Lerma F, Mart&#x000ed;nez S, Ferrer M, Avellanas M, Granada R, Marav&#x000ed;-Poma E, Albert P, Sierra R, Vidaur L, Ortiz P, Prieto del Portillo I, Galv&#x000e1;n B, Le&#x000f3;n-Gil C. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. <span><span class="ref-journal">Crit Care. </span>2009;<span class="ref-vol">13</span>:R148. doi: 10.1186/cc8044.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2784367/">PMC free article</a>]</span> [<a href="/pubmed/19747383" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2Fcc8044" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care&amp;title=Intensive+care+adult+patients+with+severe+respiratory+failure+caused+by+Influenza+A+(H1N1)v+in+Spain&amp;author=J+Rello&amp;author=A+Rodr&#x000ed;guez&amp;author=P+Iba&#x000f1;ez&amp;author=L+Socias&amp;author=J+Cebrian&amp;volume=13&amp;publication_year=2009&amp;pages=R148&amp;pmid=19747383&amp;doi=10.1186/cc8044&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, Miller MA. Severe respiratory disease concurrent with the circulation of H1N1 influenza. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">361</span>:674\xe2\x80\x93679. doi: 10.1056/NEJMoa0904023.</span> [<a href="/pubmed/19564633" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa0904023" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Severe+respiratory+disease+concurrent+with+the+circulation+of+H1N1+influenza&amp;author=G+Chowell&amp;author=SM+Bertozzi&amp;author=MA+Colchero&amp;author=H+Lopez-Gatell&amp;author=C+Alpuche-Aranda&amp;volume=361&amp;publication_year=2009&amp;pages=674-679&amp;pmid=19564633&amp;doi=10.1056/NEJMoa0904023&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. <span><span class="ref-journal">Euro Surveill. </span>2009;<span class="ref-vol">14</span>:19309.</span> [<a href="/pubmed/19712643" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Euro+Surveill&amp;title=Epidemiology+of+fatal+cases+associated+with+pandemic+H1N1+influenza+2009&amp;author=L+Vaillant&amp;author=G+La+Ruche&amp;author=A+Tarantola&amp;author=P+Barboza&amp;volume=14&amp;publication_year=2009&amp;pages=19309&amp;pmid=19712643&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, et al.  In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. <span><span class="ref-journal">Nature. </span>2009;<span class="ref-vol">460</span>:1021\xe2\x80\x931025.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2748827/">PMC free article</a>]</span> [<a href="/pubmed/19672242" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=In+vitro+and+in+vivo+characterization+of+new+swine-origin+H1N1+influenza+viruses&amp;author=Y+Itoh&amp;author=K+Shinya&amp;author=M+Kiso&amp;author=T+Watanabe&amp;author=Y+Sakoda&amp;volume=460&amp;publication_year=2009&amp;pages=1021-1025&amp;pmid=19672242&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, Turner PV, Ran R, Danesh A, Fang Y, Chan PK, Mytle N, Sullivan TJ, Collins TL, Johnson MG, Medina JC, Rowe T, Kelvin DJ. Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. <span><span class="ref-journal">J Virol. </span>2008;<span class="ref-vol">82</span>:11308\xe2\x80\x9311317. doi: 10.1128/JVI.00691-08.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2573250/">PMC free article</a>]</span> [<a href="/pubmed/18684821" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.00691-08" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Gene+expression+analysis+of+host+innate+immune+responses+during+Lethal+H5N1+infection+in+ferrets&amp;author=CM+Cameron&amp;author=MJ+Cameron&amp;author=JF+Bermejo-Martin&amp;author=L+Ran&amp;author=L+Xu&amp;volume=82&amp;publication_year=2008&amp;pages=11308-11317&amp;pmid=18684821&amp;doi=10.1128/JVI.00691-08&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Cameron MJ, Bermejo-Martin JF, Danesh A, Muller MP, Kelvin DJ. Human immunopathogenesis of severe acute respiratory syndrome (SARS) <span><span class="ref-journal">Virus Res. </span>2008;<span class="ref-vol">133</span>:13\xe2\x80\x9319. doi: 10.1016/j.virusres.2007.02.014.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7114310/">PMC free article</a>]</span> [<a href="/pubmed/17374415" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.virusres.2007.02.014" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virus+Res&amp;title=Human+immunopathogenesis+of+severe+acute+respiratory+syndrome+(SARS)&amp;author=MJ+Cameron&amp;author=JF+Bermejo-Martin&amp;author=A+Danesh&amp;author=MP+Muller&amp;author=DJ+Kelvin&amp;volume=133&amp;publication_year=2008&amp;pages=13-19&amp;pmid=17374415&amp;doi=10.1016/j.virusres.2007.02.014&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, Muller MP, Gold WL, Richardson SE, Poutanen SM, Willey BM, DeVries ME, Fang Y, Seneviratne C, Bosinger SE, Persad D, Wilkinson P, Greller LD, Somogyi R, Humar A, Keshavjee S, Louie M, Loeb MB, Brunton J, McGeer AJ, Canadian SARS Research Network. Kelvin DJ. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. <span><span class="ref-journal">J Virol. </span>2007;<span class="ref-vol">81</span>:8692\xe2\x80\x938706. doi: 10.1128/JVI.00527-07.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1951379/">PMC free article</a>]</span> [<a href="/pubmed/17537853" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.00527-07" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Interferon-mediated+immunopathological+events+are+associated+with+atypical+innate+and+adaptive+immune+responses+in+patients+with+severe+acute+respiratory+syndrome&amp;author=MJ+Cameron&amp;author=L+Ran&amp;author=L+Xu&amp;author=A+Danesh&amp;author=JF+Bermejo-Martin&amp;volume=81&amp;publication_year=2007&amp;pages=8692-8706&amp;pmid=17537853&amp;doi=10.1128/JVI.00527-07&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Bermejo-Martin JF, Garcia-Arevalo MC, Alonso A, De Lejarazu RO, Pino M, Resino S, Tenorio A, Bernardo D, Leon AJ, Garrote JA, Ardura J, Dominguez-Gil M, Eiros JM, Blanco-Quiros A, Munoz-Fernandez MA, Kelvin DJ, Arranz E. Persistence of proinflammatory response after severe respiratory syncytial virus disease in children. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2007;<span class="ref-vol">119</span>:1547\xe2\x80\x931550. doi: 10.1016/j.jaci.2007.03.014.</span> [<a href="/pubmed/17451801" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jaci.2007.03.014" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol&amp;title=Persistence+of+proinflammatory+response+after+severe+respiratory+syncytial+virus+disease+in+children&amp;author=JF+Bermejo-Martin&amp;author=MC+Garcia-Arevalo&amp;author=A+Alonso&amp;author=RO+De+Lejarazu&amp;author=M+Pino&amp;volume=119&amp;publication_year=2007&amp;pages=1547-1550&amp;pmid=17451801&amp;doi=10.1016/j.jaci.2007.03.014&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. <span><span class="ref-journal">Nat Med. </span>2006;<span class="ref-vol">12</span>:1203\xe2\x80\x931207. doi: 10.1038/nm1477.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4333202/">PMC free article</a>]</span> [<a href="/pubmed/16964257" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnm1477" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Fatal+outcome+of+human+influenza+A+(H5N1)+is+associated+with+high+viral+load+and+hypercytokinemia&amp;author=MD+de+Jong&amp;author=CP+Simmons&amp;author=TT+Thanh&amp;author=VM+Hien&amp;author=GJ+Smith&amp;volume=12&amp;publication_year=2006&amp;pages=1203-1207&amp;pmid=16964257&amp;doi=10.1038/nm1477&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Kendal AP, Pereira MS, Skehel JJ.  <span class="ref-journal">US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta, Georgia.</span> 1982. Concepts and procedures for laboratory-based influenza surveillance. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=US+Department+of+Health+and+Human+Services,+Public+Health+Service,+Centers+for+Disease+Control,+Atlanta,+Georgia&amp;author=AP+Kendal&amp;author=MS+Pereira&amp;author=JJ+Skehel&amp;publication_year=1982&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Fietta P, Delsante G. The effector T helper cell triade. <span><span class="ref-journal">Riv Biol. </span>2009;<span class="ref-vol">102</span>:61\xe2\x80\x9374.</span> [<a href="/pubmed/19718623" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Riv+Biol&amp;title=The+effector+T+helper+cell+triade&amp;author=P+Fietta&amp;author=G+Delsante&amp;volume=102&amp;publication_year=2009&amp;pages=61-74&amp;pmid=19718623&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Nalbandian A, Crispin JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. <span><span class="ref-journal">Clin Exp Immunol. </span>2009;<span class="ref-vol">157</span>:209\xe2\x80\x93215. doi: 10.1111/j.1365-2249.2009.03944.x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2730846/">PMC free article</a>]</span> [<a href="/pubmed/19604260" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1365-2249.2009.03944.x" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Immunol&amp;title=Interleukin-17+and+systemic+lupus+erythematosus:+current+concepts&amp;author=A+Nalbandian&amp;author=JC+Crispin&amp;author=GC+Tsokos&amp;volume=157&amp;publication_year=2009&amp;pages=209-215&amp;pmid=19604260&amp;doi=10.1111/j.1365-2249.2009.03944.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. <span><span class="ref-journal">Annu Rev Immunol. </span>2009;<span class="ref-vol">27</span>:485\xe2\x80\x93517. doi: 10.1146/annurev.immunol.021908.132710.</span> [<a href="/pubmed/19132915" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1146%2Fannurev.immunol.021908.132710" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Immunol&amp;title=IL-17+and+Th17+Cells&amp;author=T+Korn&amp;author=E+Bettelli&amp;author=M+Oukka&amp;author=VK+Kuchroo&amp;volume=27&amp;publication_year=2009&amp;pages=485-517&amp;pmid=19132915&amp;doi=10.1146/annurev.immunol.021908.132710&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Louten J, Boniface K, de Waal Malefyt R. Development and function of TH17 cells in health and disease. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2009;<span class="ref-vol">123</span>:1004\xe2\x80\x931011. doi: 10.1016/j.jaci.2009.04.003.</span> [<a href="/pubmed/19410689" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jaci.2009.04.003" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol&amp;title=Development+and+function+of+TH17+cells+in+health+and+disease&amp;author=J+Louten&amp;author=K+Boniface&amp;author=R+de+Waal+Malefyt&amp;volume=123&amp;publication_year=2009&amp;pages=1004-1011&amp;pmid=19410689&amp;doi=10.1016/j.jaci.2009.04.003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J, Bettelli E, Oukka M, van Snick J, Renauld JC, Kuchroo VK, Khoury SJ. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2009;<span class="ref-vol">106</span>:12885\xe2\x80\x9312890. doi: 10.1073/pnas.0812530106.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2722314/">PMC free article</a>]</span> [<a href="/pubmed/19433802" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.0812530106" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=IL-9+induces+differentiation+of+TH17+cells+and+enhances+function+of+FoxP3++natural+regulatory+T+cells&amp;author=W+Elyaman&amp;author=EM+Bradshaw&amp;author=C+Uyttenhove&amp;author=V+Dardalhon&amp;author=A+Awasthi&amp;volume=106&amp;publication_year=2009&amp;pages=12885-12890&amp;pmid=19433802&amp;doi=10.1073/pnas.0812530106&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Cheung PF, Wong CK, Lam CW. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. <span><span class="ref-journal">J Immunol. </span>2008;<span class="ref-vol">180</span>:5625\xe2\x80\x935635. doi: 10.4049/jimmunol.180.8.5625.</span> [<a href="/pubmed/18390747" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.4049%2Fjimmunol.180.8.5625" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Molecular+mechanisms+of+cytokine+and+chemokine+release+from+eosinophils+activated+by+IL-17A,+IL-17F,+and+IL-23:+implication+for+Th17+lymphocytes-mediated+allergic+inflammation&amp;author=PF+Cheung&amp;author=CK+Wong&amp;author=CW+Lam&amp;volume=180&amp;publication_year=2008&amp;pages=5625-5635&amp;pmid=18390747&amp;doi=10.4049/jimmunol.180.8.5625&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">GeurtsvanKessel CH, Bergen IM, Muskens F, Boon L, Hoogsteden HC, Osterhaus AD, Rimmelzwaan GF, Lambrecht BN. Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection. <span><span class="ref-journal">PLoS One. </span>2009;<span class="ref-vol">4</span>:e7187. doi: 10.1371/journal.pone.0007187.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2747012/">PMC free article</a>]</span> [<a href="/pubmed/19784375" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1371%2Fjournal.pone.0007187" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Both+conventional+and+interferon+killer+dendritic+cells+have+antigen-presenting+capacity+during+influenza+virus+infection&amp;author=CH+GeurtsvanKessel&amp;author=IM+Bergen&amp;author=F+Muskens&amp;author=L+Boon&amp;author=HC+Hoogsteden&amp;volume=4&amp;publication_year=2009&amp;pages=e7187&amp;pmid=19784375&amp;doi=10.1371/journal.pone.0007187&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. <span><span class="ref-journal">Cytokine Growth Factor Rev. </span>2001;<span class="ref-vol">12</span>:171\xe2\x80\x93180. doi: 10.1016/S1359-6101(00)00026-5.</span> [<a href="/pubmed/11325600" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS1359-6101(00)00026-5" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cytokine+Growth+Factor+Rev&amp;title=Molecular+pathogenesis+of+influenza+A+virus+infection+and+virus-induced+regulation+of+cytokine+gene+expression&amp;author=I+Julkunen&amp;author=T+Sareneva&amp;author=J+Pirhonen&amp;author=T+Ronni&amp;author=K+Melen&amp;volume=12&amp;publication_year=2001&amp;pages=171-180&amp;pmid=11325600&amp;doi=10.1016/S1359-6101(00)00026-5&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, Ceuppens JL. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? <span><span class="ref-journal">Respir Res. </span>2006;<span class="ref-vol">7</span>:135. doi: 10.1186/1465-9921-7-135.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1636037/">PMC free article</a>]</span> [<a href="/pubmed/17083726" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1465-9921-7-135" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Respir+Res&amp;title=IL-17+mRNA+in+sputum+of+asthmatic+patients:+linking+T+cell+driven+inflammation+and+granulocytic+influx?&amp;author=DM+Bullens&amp;author=E+Truyen&amp;author=L+Coteur&amp;author=E+Dilissen&amp;author=PW+Hellings&amp;volume=7&amp;publication_year=2006&amp;pages=135&amp;pmid=17083726&amp;doi=10.1186/1465-9921-7-135&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Newcomb DC, Zhou W, Moore ML, Goleniewska K, Hershey GK, Kolls JK, Peebles RS., Jr A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production. <span><span class="ref-journal">J Immunol. </span>2009;<span class="ref-vol">182</span>:5317\xe2\x80\x935321. doi: 10.4049/jimmunol.0803868.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3711250/">PMC free article</a>]</span> [<a href="/pubmed/19380778" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.4049%2Fjimmunol.0803868" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=A+functional+IL-13+receptor+is+expressed+on+polarized+murine+CD4++Th17+cells+and+IL-13+signaling+attenuates+Th17+cytokine+production&amp;author=DC+Newcomb&amp;author=W+Zhou&amp;author=ML+Moore&amp;author=K+Goleniewska&amp;author=GK+Hershey&amp;volume=182&amp;publication_year=2009&amp;pages=5317-5321&amp;pmid=19380778&amp;doi=10.4049/jimmunol.0803868&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, Huston G, Tighe M, Hamada H, Sell S, Dutton RW, Swain SL. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. <span><span class="ref-journal">J Immunol. </span>2009;<span class="ref-vol">182</span>:7353\xe2\x80\x937363. doi: 10.4049/jimmunol.0900657.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2724021/">PMC free article</a>]</span> [<a href="/pubmed/19494257" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.4049%2Fjimmunol.0900657" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=IL-10+deficiency+unleashes+an+influenza-specific+Th17+response+and+enhances+survival+against+high-dose+challenge&amp;author=KK+McKinstry&amp;author=TM+Strutt&amp;author=A+Buck&amp;author=JD+Curtis&amp;author=JP+Dibble&amp;volume=182&amp;publication_year=2009&amp;pages=7353-7363&amp;pmid=19494257&amp;doi=10.4049/jimmunol.0900657&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Korn T, Mitsdoerffer M, Croxford AL, Awasthi A, Dardalhon VA, Galileos G, Vollmar P, Stritesky GL, Kaplan MH, Waisman A, Kuchroo VK, Oukka M. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2008;<span class="ref-vol">105</span>:18460\xe2\x80\x9318465. doi: 10.1073/pnas.0809850105.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2587589/">PMC free article</a>]</span> [<a href="/pubmed/19015529" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.0809850105" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=IL-6+controls+Th17+immunity+in+vivo+by+inhibiting+the+conversion+of+conventional+T+cells+into+Foxp3++regulatory+T+cells&amp;author=T+Korn&amp;author=M+Mitsdoerffer&amp;author=AL+Croxford&amp;author=A+Awasthi&amp;author=VA+Dardalhon&amp;volume=105&amp;publication_year=2008&amp;pages=18460-18465&amp;pmid=19015529&amp;doi=10.1073/pnas.0809850105&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Shen CH, Ge Q, Talay O, Eisen HN, Garcia-Sastre A, Chen J. Loss of IL-7R and IL-15R expression is associated with disappearance of memory T cells in respiratory tract following influenza infection. <span><span class="ref-journal">J Immunol. </span>2008;<span class="ref-vol">180</span>:171\xe2\x80\x93178. doi: 10.4049/jimmunol.180.1.171.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2709277/">PMC free article</a>]</span> [<a href="/pubmed/18097017" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.4049%2Fjimmunol.180.1.171" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Loss+of+IL-7R+and+IL-15R+expression+is+associated+with+disappearance+of+memory+T+cells+in+respiratory+tract+following+influenza+infection&amp;author=CH+Shen&amp;author=Q+Ge&amp;author=O+Talay&amp;author=HN+Eisen&amp;author=A+Garcia-Sastre&amp;volume=180&amp;publication_year=2008&amp;pages=171-178&amp;pmid=18097017&amp;doi=10.4049/jimmunol.180.1.171&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Garulli B, Castrucci MR. Protective immunity to influenza: lessons from the virus for successful vaccine design. <span><span class="ref-journal">Expert Rev Vaccines. </span>2009;<span class="ref-vol">8</span>:689\xe2\x80\x93693. doi: 10.1586/erv.09.35.</span> [<a href="/pubmed/19485749" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1586%2Ferv.09.35" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Rev+Vaccines&amp;title=Protective+immunity+to+influenza:+lessons+from+the+virus+for+successful+vaccine+design&amp;author=B+Garulli&amp;author=MR+Castrucci&amp;volume=8&amp;publication_year=2009&amp;pages=689-693&amp;pmid=19485749&amp;doi=10.1586/erv.09.35&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, McKinstry KK, Cooper AM, Swain SL, Dutton RW. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. <span><span class="ref-journal">J Immunol. </span>2009;<span class="ref-vol">182</span>:3469\xe2\x80\x933481. doi: 10.4049/jimmunol.0801814.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2667713/">PMC free article</a>]</span> [<a href="/pubmed/19265125" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.4049%2Fjimmunol.0801814" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Tc17,+a+unique+subset+of+CD8+T+cells+that+can+protect+against+lethal+influenza+challenge&amp;author=H+Hamada&amp;author=L+Garcia-Hernandez+Mde&amp;author=JB+Reome&amp;author=SK+Misra&amp;author=TM+Strutt&amp;volume=182&amp;publication_year=2009&amp;pages=3469-3481&amp;pmid=19265125&amp;doi=10.4049/jimmunol.0801814&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI, Ross TM, Witztum JL, Kolls JK. Critical role of IL-17RA in immunopathology of influenza infection. <span><span class="ref-journal">J Immunol. </span>2009;<span class="ref-vol">183</span>:5301\xe2\x80\x935310. doi: 10.4049/jimmunol.0900995.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3638739/">PMC free article</a>]</span> [<a href="/pubmed/19783685" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.4049%2Fjimmunol.0900995" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Critical+role+of+IL-17RA+in+immunopathology+of+influenza+infection&amp;author=CR+Crowe&amp;author=K+Chen&amp;author=DA+Pociask&amp;author=JF+Alcorn&amp;author=C+Krivich&amp;volume=183&amp;publication_year=2009&amp;pages=5301-5310&amp;pmid=19783685&amp;doi=10.4049/jimmunol.0900995&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Fedson DS. Confronting an influenza pandemic with inexpensive generic agents: can it be done? <span><span class="ref-journal">Lancet Infect Dis. </span>2008;<span class="ref-vol">8</span>:571\xe2\x80\x93576. doi: 10.1016/S1473-3099(08)70070-7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7128266/">PMC free article</a>]</span> [<a href="/pubmed/18420459" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS1473-3099(08)70070-7" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Infect+Dis&amp;title=Confronting+an+influenza+pandemic+with+inexpensive+generic+agents:+can+it+be+done?&amp;author=DS+Fedson&amp;volume=8&amp;publication_year=2008&amp;pages=571-576&amp;pmid=18420459&amp;doi=10.1016/S1473-3099(08)70070-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2811892&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2811892/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2811892/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2811892/pdf/13054_2009_Article_7626.pdf">PDF (1.0M)</a></li> | <li><a href="#" data-citationid="PMC2811892" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2811892%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2811892%2F&amp;text=Th1%20and%20Th17%20hypercytokinemia%20as%20early%20host%20response%20signature%20in%20severe%20pandemic%20influenza"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2811892%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="20003352" data-aiid="7097828" data-aid="2811892" data-iid="354832" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC2811892" data-md5="bd3b9eafa03865bbe825b684bfc2b21a"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:30:43-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A05D1E9A3F72100000000046D046A&amp;ncbi_session=8A1A05D1E9A4A321_1133SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2811892%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2811892/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A05D1E9A4A321_1133SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'